<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.18c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: ECPN 0331 10Q.xfr; Date: 2017%2D05%2D17T22:20:05Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80060000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2017-01-31" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:ecpn="http://elcaptain.com/20170331">
    <link:schemaRef xlink:href="ecpn-20170331.xsd" xlink:type="simple" />
    <xbrli:context id="E15Q3">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I151008">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-10-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I151215">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I160114">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-01-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I151014">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-10-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-01-31_custom_ManagementResourcesInitiativesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ecpn:ManagementResourcesInitiativesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-08-01to2013-08-31_custom_ManagementResourcesInitiativesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ecpn:ManagementResourcesInitiativesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-08-01</xbrli:startDate>
        <xbrli:endDate>2013-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-02-01to2014-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-02-01</xbrli:startDate>
        <xbrli:endDate>2014-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-02-01to2014-02-28_custom_LogisticaNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:LogisticaNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-02-01</xbrli:startDate>
        <xbrli:endDate>2014-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-02-28_custom_LogisticaNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:LogisticaNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-16to2014-10-17_custom_NoteAndWarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:NoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-16</xbrli:startDate>
        <xbrli:endDate>2014-10-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-10-17_custom_NoteAndWarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:NoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-10-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-08-24_custom_NoteAndWarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:NoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-08-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-01-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-01-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_OfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_custom_ManagementResourcesInitiativesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ecpn:ManagementResourcesInitiativesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-02-01to2015-02-04_us-gaap_UnsecuredDebtMember_custom_MriMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:MriMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-02-01</xbrli:startDate>
        <xbrli:endDate>2015-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-02-04_us-gaap_UnsecuredDebtMember_custom_MriMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:MriMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-02-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-02-01to2015-02-04_us-gaap_UnsecuredDebtMember_custom_MriMember_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:MriMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-02-01</xbrli:startDate>
        <xbrli:endDate>2015-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-01-05_custom_LogisticaNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:LogisticaNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-01-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-01-19_custom_NoteAndWarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:NoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-01-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-02-01to2015-02-04_us-gaap_UnsecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-02-01</xbrli:startDate>
        <xbrli:endDate>2015-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-02-01to2015-02-04_us-gaap_UnsecuredDebtMember_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-02-01</xbrli:startDate>
        <xbrli:endDate>2015-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-02-01to2016-02-04_us-gaap_UnsecuredDebtMember_custom_ConvesionAgreementMember_custom_MriMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:MriMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-02-01</xbrli:startDate>
        <xbrli:endDate>2016-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-02-01to2016-02-04_us-gaap_UnsecuredDebtMember_us-gaap_RestrictedStockMember_custom_MriMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:MriMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-02-01</xbrli:startDate>
        <xbrli:endDate>2016-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-08-01to2015-08-15_custom_InsuranceFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InsuranceFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-08-01</xbrli:startDate>
        <xbrli:endDate>2015-08-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-08-15_custom_InsuranceFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InsuranceFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-08-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-11-01to2016-11-14_custom_InsuranceFinancingAgreementMember_us-gaap_OfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InsuranceFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-11-01</xbrli:startDate>
        <xbrli:endDate>2016-11-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-11-14_custom_InsuranceFinancingAgreementMember_us-gaap_OfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InsuranceFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-11-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-08-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-08-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-08-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-08-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-04-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-04-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-11-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-11-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-10-01to2016-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-10-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_us-gaap_OfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_custom_ContractMinersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">ecpn:ContractMinersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_EquityIncentivePlan2015Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ecpn:EquityIncentivePlan2015Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_ChiefFinancialOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefFinancialOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_InsuranceFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InsuranceFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_InsuranceFinancingAgreementMember_us-gaap_OfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InsuranceFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_NoteAndWarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:NoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_LogisticaNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:LogisticaNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_us-gaap_OfficerMember_us-gaap_RestrictedStockMember_custom_FormerOfficerAndCurrentDirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ecpn:FormerOfficerAndCurrentDirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_OfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_ManagementResourcesInitiativesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ecpn:ManagementResourcesInitiativesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_UnsecuredDebtMember_custom_MriMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:MriMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_us-gaap_UnsecuredDebtMember_custom_MriMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:MriMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-10-01to2016-03-31_us-gaap_UnsecuredDebtMember_custom_MriMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:MriMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-10-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-05-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-05-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_PurchaseAgreementWithL2CapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ecpn:PurchaseAgreementWithL2CapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_us-gaap_InvestorMember_us-gaap_RestrictedStockMember_us-gaap_OfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_custom_InvestorOneMember_us-gaap_RestrictedStockMember_custom_JohnFStapletonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ecpn:JohnFStapletonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_ConvesionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:ConvesionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_custom_ConvesionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:ConvesionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-02-01to2017-02-23_custom_InsuranceFinancingAgreementMember_custom_FordFourFiftyTruckMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InsuranceFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">ecpn:FordFourFiftyTruckMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-02-01</xbrli:startDate>
        <xbrli:endDate>2017-02-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-02-23_custom_InsuranceFinancingAgreementMember_custom_FordFourFiftyTruckMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InsuranceFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">ecpn:FordFourFiftyTruckMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-02-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_InsuranceFinancingAgreementMember_custom_FordFourFiftyTruckMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InsuranceFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">ecpn:FordFourFiftyTruckMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InvestorAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-02-21_us-gaap_NoteWarrantMember_custom_InvestorAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InvestorAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-02-21_us-gaap_NotesPayableOtherPayablesMember_custom_InvestorAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InvestorAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_NoteWarrantMember_custom_InvestorAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InvestorAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-02-01to2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InvestorAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-02-01</xbrli:startDate>
        <xbrli:endDate>2017-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_custom_TwoThousandsSixteenPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ecpn:TwoThousandsSixteenPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_custom_TwoThousandsSeventeenPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ecpn:TwoThousandsSeventeenPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_custom_NoteAndWarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:NoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_ConversionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:ConversionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-02-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-01to2017-05-18_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-01</xbrli:startDate>
        <xbrli:endDate>2017-05-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-10-01to2016-03-31_custom_ManagementResourcesInitiativesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ecpn:ManagementResourcesInitiativesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-10-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_custom_ManagementResourcesInitiativesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ecpn:ManagementResourcesInitiativesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-04to2016-01-05_custom_LogisticaNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:LogisticaNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-04</xbrli:startDate>
        <xbrli:endDate>2016-01-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_custom_FormerOfficerAndCurrentDirectorMember_custom_S8CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ecpn:FormerOfficerAndCurrentDirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ecpn:S8CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_custom_FormerOfficerAndCurrentDirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ecpn:FormerOfficerAndCurrentDirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-05-01_us-gaap_OfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-05-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_us-gaap_OfficerMember_custom_S8CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ecpn:S8CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_us-gaap_OfficerMember279923343">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_custom_JohnFStapletonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ecpn:JohnFStapletonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_custom_JohnFStapletonMember_custom_S8CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ecpn:JohnFStapletonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ecpn:S8CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-03-28to2017-03-29_us-gaap_UnsecuredDebtMember_custom_MriMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:MriMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-03-28</xbrli:startDate>
        <xbrli:endDate>2017-03-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_us-gaap_RestrictedStockMember_custom_AccruedLegalFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ecpn:AccruedLegalFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_custom_S8CommonStockMember_custom_AccruedLegalFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ecpn:S8CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ecpn:AccruedLegalFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-03-31_custom_AccruedLegalFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ecpn:AccruedLegalFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-02-04_us-gaap_UnsecuredDebtMember_custom_MriMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:MriMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-02-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-08-01to2016-08-31_custom_LogisticaNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:LogisticaNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-08-01</xbrli:startDate>
        <xbrli:endDate>2016-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-08-23to2015-08-24_custom_NoteAndWarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:NoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-08-23</xbrli:startDate>
        <xbrli:endDate>2015-08-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-18to2016-01-19_custom_NoteAndWarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:NoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-18</xbrli:startDate>
        <xbrli:endDate>2016-01-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_NoteAndWarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:NoteAndWarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-30_custom_InvestorAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InvestorAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-02-01to2016-02-04_us-gaap_UnsecuredDebtMember_custom_OneOfTheLendersAffiliatedWithTheCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:OneOfTheLendersAffiliatedWithTheCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-02-01</xbrli:startDate>
        <xbrli:endDate>2016-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-02-04_us-gaap_UnsecuredDebtMember_custom_OneOfTheLendersAffiliatedWithTheCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:OneOfTheLendersAffiliatedWithTheCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-02-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-02-01to2016-02-04_us-gaap_UnsecuredDebtMember_custom_OneOfTheLendersAffiliatedWithTheCompanyMember_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:OneOfTheLendersAffiliatedWithTheCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-02-01</xbrli:startDate>
        <xbrli:endDate>2016-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_InvestorAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InvestorAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_InvestorAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InvestorAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_InvestorAgreementMember_us-gaap_NotesPayableOtherPayablesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ecpn:InvestorAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-02-20to2017-02-21_custom_L2CapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">ecpn:L2CapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-02-20</xbrli:startDate>
        <xbrli:endDate>2017-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-02-20to2017-02-21_custom_L2CapitalMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">ecpn:L2CapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-02-20</xbrli:startDate>
        <xbrli:endDate>2017-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-02-20to2017-02-21_custom_L2CapitalMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">ecpn:L2CapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-02-20</xbrli:startDate>
        <xbrli:endDate>2017-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-02-21_custom_L2CapitalMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001135202</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">ecpn:L2CapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="UsdPerShare">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">128748</us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">168235</us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">51</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">51</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">51</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">51</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2016-09-30" unitRef="UsdPerShare" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-03-31" unitRef="UsdPerShare" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-09-30" unitRef="UsdPerShare" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2017-03-31" unitRef="UsdPerShare" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-09-28" unitRef="Shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-09-27" unitRef="Shares" decimals="INF">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">366254777</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">403745200</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:InventoryOreStockpilesOnLeachPads contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">87840</us-gaap:InventoryOreStockpilesOnLeachPads>
    <us-gaap:InventoryOreStockpilesOnLeachPads contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">87840</us-gaap:InventoryOreStockpilesOnLeachPads>
    <ecpn:AccruedMiningCosts contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">60613</ecpn:AccruedMiningCosts>
    <ecpn:AccruedMiningCosts contextRef="AsOf2017-03-31" unitRef="USD" xsi:nil="true" />
    <ecpn:RestrictedCashConsistsOfTwoCertificatesOfDepositsInFavorOfNewMexicoMineralsAndMiningDivision contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">79857</ecpn:RestrictedCashConsistsOfTwoCertificatesOfDepositsInFavorOfNewMexicoMineralsAndMiningDivision>
    <us-gaap:Revenues contextRef="From2016-10-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2017-01-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2016-01-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">2950</us-gaap:Revenues>
    <us-gaap:GrossProfit contextRef="From2016-10-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GrossProfit contextRef="From2017-01-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GrossProfit contextRef="From2016-01-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GrossProfit contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">-350</us-gaap:GrossProfit>
    <us-gaap:ProfessionalFees contextRef="From2013-08-01to2013-08-31_custom_ManagementResourcesInitiativesIncMember" unitRef="USD" decimals="0">15000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">14011</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">11020</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">53257</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">102761</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2015-10-01to2016-03-31_custom_ManagementResourcesInitiativesIncMember" unitRef="USD" decimals="0">45000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2016-10-01to2017-03-31_custom_ManagementResourcesInitiativesIncMember" unitRef="USD" decimals="0">45000</us-gaap:ProfessionalFees>
    <us-gaap:AdministrativeFeesExpense contextRef="From2012-01-01to2012-01-31_custom_ManagementResourcesInitiativesIncMember" unitRef="USD" decimals="0">15000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">130000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">65000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">65000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">130000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="From2015-10-01to2016-03-31_custom_ManagementResourcesInitiativesIncMember" unitRef="USD" decimals="0">90000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="From2016-10-01to2017-03-31_custom_ManagementResourcesInitiativesIncMember" unitRef="USD" decimals="0">90000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">64276</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">34866</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">11711</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">86903</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">774465</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">463291</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">277671</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">648229</us-gaap:OperatingExpenses>
    <us-gaap:InvestmentIncomeInterest contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">16</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">3</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">4</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">6</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpenseRelatedParty contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">2693</us-gaap:InterestExpenseRelatedParty>
    <us-gaap:InterestExpenseRelatedParty contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">1711</us-gaap:InterestExpenseRelatedParty>
    <us-gaap:InterestExpenseRelatedParty contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">4689</us-gaap:InterestExpenseRelatedParty>
    <us-gaap:InterestExpenseRelatedParty contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">7145</us-gaap:InterestExpenseRelatedParty>
    <us-gaap:InterestExpenseOther contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">33235</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">19477</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">26714</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">127573</us-gaap:InterestExpenseOther>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">-919611</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">-782774</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">102857</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">-81033</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2016-10-01to2017-03-31" unitRef="UsdPerShare" decimals="INF">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-01-01to2017-03-31" unitRef="UsdPerShare" decimals="INF">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2016-01-01to2016-03-31" unitRef="UsdPerShare" decimals="INF">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2015-10-01to2016-03-31" unitRef="UsdPerShare" decimals="INF">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2016-10-01to2017-03-31" unitRef="Shares" decimals="INF">382557536</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2017-01-01to2017-03-31" unitRef="Shares" decimals="INF">388188740</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2016-01-01to2016-03-31" unitRef="Shares" decimals="INF">308873495</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2015-10-01to2016-03-31" unitRef="Shares" decimals="INF">307681187</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLoss contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">-1694076</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">-1246065</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">-174814</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">-729612</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">206813</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">109991</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">9343</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">88692</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2016-10-01to2017-03-31_us-gaap_UnsecuredDebtMember_custom_MriMember" unitRef="USD" decimals="0">1769</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2015-10-01to2016-03-31_us-gaap_UnsecuredDebtMember_custom_MriMember" unitRef="USD" decimals="0">8976</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2017-01-01to2017-03-31_custom_InvestorAgreementMember" unitRef="USD" decimals="0">7574</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:Depreciation contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">41347</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">32941</us-gaap:Depreciation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">-660376</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">-538266</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">-16774</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">-101044</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2016-10-01to2017-03-31_us-gaap_OfficerMember" unitRef="USD" decimals="0">385110</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2016-10-01to2017-03-31_us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" unitRef="USD" decimals="0">248799</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2016-10-01to2017-03-31_custom_ConvesionAgreementMember" unitRef="USD" decimals="0">10209</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2016-10-01to2017-03-31_custom_FormerOfficerAndCurrentDirectorMember" unitRef="USD" decimals="0">-54110</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2016-10-01to2017-03-31_us-gaap_OfficerMember279923343" unitRef="USD" decimals="0">-46732</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2016-10-01to2017-03-31_custom_JohnFStapletonMember" unitRef="USD" decimals="0">-284268</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2016-10-01to2017-03-31_custom_AccruedLegalFeesMember" unitRef="USD" decimals="0">-248799</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">-223323</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">-223323</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">151030</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">154723</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">15037</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">7906</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2016-10-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">156703</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">60964</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">28630</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">-6232</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">126550</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInRestrictedCash contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">5353</us-gaap:IncreaseDecreaseInRestrictedCash>
    <us-gaap:IncreaseDecreaseInRestrictedCash contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">3</us-gaap:IncreaseDecreaseInRestrictedCash>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2015-02-01to2015-02-04_us-gaap_UnsecuredDebtMember" unitRef="USD" decimals="0">63000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:PaymentsOfFinancingCosts contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">30349</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">25249</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">-272421</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">11991</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="E15Q3" unitRef="USD" decimals="0">71393</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">296619</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">24198</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-03-31" unitRef="USD" decimals="0">83384</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">7616</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">21079</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2016-10-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaidNet contextRef="From2015-10-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <ecpn:CommonStockIssuedForThirdPartyPayables contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">236756</ecpn:CommonStockIssuedForThirdPartyPayables>
    <ecpn:CommonStockIssuedForThirdPartyPayables contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">217431</ecpn:CommonStockIssuedForThirdPartyPayables>
    <ecpn:CommonStockIssuedOnSettlementOfDebtAndAccruedInterest contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">256027</ecpn:CommonStockIssuedOnSettlementOfDebtAndAccruedInterest>
    <ecpn:CommonStockIssuedOnSettlementOfDebtAndAccruedInterest contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">307982</ecpn:CommonStockIssuedOnSettlementOfDebtAndAccruedInterest>
    <ecpn:CommonStockIssuedForInventory contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">3784</ecpn:CommonStockIssuedForInventory>
    <ecpn:CommonStockIssuedForInventory contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">439603</ecpn:CommonStockIssuedForInventory>
    <ecpn:DebtDiscountFromDerivativeLiabilities contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">88329</ecpn:DebtDiscountFromDerivativeLiabilities>
    <ecpn:DebtDiscountFromDerivativeLiabilities contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">92000</ecpn:DebtDiscountFromDerivativeLiabilities>
    <ecpn:ReclassificationOfWarrantsFromEquityToDerivativeLiabilities contextRef="From2016-10-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <ecpn:ReclassificationOfWarrantsFromEquityToDerivativeLiabilities contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">205526</ecpn:ReclassificationOfWarrantsFromEquityToDerivativeLiabilities>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2017-05-18" unitRef="Shares" decimals="INF">409752582</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">500000</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent contextRef="AsOf2016-09-30_us-gaap_OfficerMember" unitRef="USD" decimals="0">40000</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent contextRef="AsOf2016-09-30_custom_ManagementResourcesInitiativesIncMember" unitRef="USD" decimals="0">315000</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">33983</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent contextRef="AsOf2017-03-31_us-gaap_ChiefFinancialOfficerMember" unitRef="USD" decimals="0">11483</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent contextRef="AsOf2017-03-31_us-gaap_OfficerMember" unitRef="USD" decimals="0">11483</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent contextRef="AsOf2017-03-31_custom_ManagementResourcesInitiativesIncMember" unitRef="USD" decimals="0">22500</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">1769</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent contextRef="AsOf2017-03-31_us-gaap_UnsecuredDebtMember_custom_MriMember" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">-774465</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">-463291</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">-277671</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">-648579</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">-479196</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">-316543</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">-122257</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">-790</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">329032</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">329324</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:ProceedsFromOtherDebt contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">25224</us-gaap:ProceedsFromOtherDebt>
    <us-gaap:ProceedsFromOtherDebt contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">32773</us-gaap:ProceedsFromOtherDebt>
    <us-gaap:StockIssued1 contextRef="From2016-10-01to2017-03-31_custom_ConvesionAgreementMember" unitRef="USD" decimals="0">266236</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="From2016-10-01to2017-03-31_custom_FormerOfficerAndCurrentDirectorMember" unitRef="USD" decimals="0">199110</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="From2016-10-01to2017-03-31_us-gaap_OfficerMember279923343" unitRef="USD" decimals="0">86732</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="From2016-10-01to2017-03-31_custom_JohnFStapletonMember" unitRef="USD" decimals="0">599268</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="From2016-10-01to2017-03-31_custom_AccruedLegalFeesMember" unitRef="USD" decimals="0">485554</us-gaap:StockIssued1>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2016-10-01to2017-03-31_us-gaap_OfficerMember" unitRef="USD" decimals="0">885110</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2016-10-01to2017-03-31_custom_FormerOfficerAndCurrentDirectorMember" unitRef="USD" decimals="0">145000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2016-10-01to2017-03-31_us-gaap_OfficerMember279923343" unitRef="USD" decimals="0">40000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2016-10-01to2017-03-31_custom_JohnFStapletonMember" unitRef="USD" decimals="0">315000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2016-10-01to2017-03-31_us-gaap_OfficerMember" unitRef="Shares" decimals="INF">6097562</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2016-10-01to2017-03-31_us-gaap_OfficerMember_us-gaap_RestrictedStockMember_custom_FormerOfficerAndCurrentDirectorMember" unitRef="Shares" decimals="INF">1768293</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2016-10-01to2017-03-31_us-gaap_InvestorMember_us-gaap_RestrictedStockMember_us-gaap_OfficerMember" unitRef="Shares" decimals="INF">487806</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2016-10-01to2017-03-31_custom_InvestorOneMember_us-gaap_RestrictedStockMember_custom_JohnFStapletonMember" unitRef="Shares" decimals="INF">3841463</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2016-10-01to2017-03-31_custom_FormerOfficerAndCurrentDirectorMember_custom_S8CommonStockMember" unitRef="Shares" decimals="INF">1768293</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2016-10-01to2017-03-31_us-gaap_OfficerMember_custom_S8CommonStockMember" unitRef="Shares" decimals="INF">487806</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2016-10-01to2017-03-31_custom_JohnFStapletonMember_custom_S8CommonStockMember" unitRef="Shares" decimals="INF">3841463</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:CostsIncurredExplorationCosts contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">1864608</us-gaap:CostsIncurredExplorationCosts>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">285025</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">83309</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:InterestAndDividendsPayableCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">61694</us-gaap:InterestAndDividendsPayableCurrent>
    <us-gaap:InterestAndDividendsPayableCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">75008</us-gaap:InterestAndDividendsPayableCurrent>
    <us-gaap:PaymentsToAcquireMiningAssets contextRef="From2014-02-01to2014-02-28" unitRef="USD" decimals="0">100000</us-gaap:PaymentsToAcquireMiningAssets>
    <us-gaap:PaymentsToAcquireMiningAssets contextRef="From2014-02-01to2014-02-28_custom_LogisticaNoteMember" unitRef="USD" decimals="0">400000</us-gaap:PaymentsToAcquireMiningAssets>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2014-02-28_custom_LogisticaNoteMember" unitRef="USD" decimals="0">400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2014-10-17_custom_NoteAndWarrantPurchaseAgreementMember" unitRef="USD" decimals="0">500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2015-02-04_us-gaap_UnsecuredDebtMember_custom_MriMember" unitRef="USD" decimals="0">30000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2017-03-31_custom_ConvesionAgreementMember" unitRef="USD" decimals="0">250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2014-02-28_custom_LogisticaNoteMember" unitRef="Pure" decimals="INF">0.0450</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2014-10-17_custom_NoteAndWarrantPurchaseAgreementMember" unitRef="Pure" decimals="INF">0.08</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2015-02-04_us-gaap_UnsecuredDebtMember_custom_MriMember" unitRef="Pure" decimals="INF">0.18</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2015-08-15_custom_InsuranceFinancingAgreementMember" unitRef="Pure" decimals="INF">0.0725</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2016-11-14_custom_InsuranceFinancingAgreementMember_us-gaap_OfficerMember" unitRef="Pure" decimals="INF">0.0500</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2017-02-23_custom_InsuranceFinancingAgreementMember_custom_FordFourFiftyTruckMember" unitRef="Pure" decimals="INF">0.0499</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="Pure" decimals="INF">0.07</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2016-02-04_us-gaap_UnsecuredDebtMember_custom_MriMember" unitRef="Pure" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2016-02-04_us-gaap_UnsecuredDebtMember_custom_OneOfTheLendersAffiliatedWithTheCompanyMember" unitRef="Pure" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2016-10-01to2017-03-31_us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" unitRef="Shares" decimals="INF">3000000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2017-04-01to2017-05-18_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">2700000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2016-10-01to2017-03-31_us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" unitRef="USD" decimals="0">485554</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2016-10-01to2017-03-31_custom_ContractMinersMember" unitRef="USD" decimals="0">38804</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">11137500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">11137500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-03-31_custom_EquityIncentivePlan2015Member" unitRef="Shares" decimals="INF">11137500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2016-10-01to2017-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2016-10-01to2017-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2016-10-01to2017-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2016-10-01to2017-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">11137500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2016-09-30" unitRef="UsdPerShare" decimals="INF">0.265</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-03-31" unitRef="UsdPerShare" decimals="INF">0.265</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2017-03-31" unitRef="UsdPerShare" decimals="INF">0.265</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">5332773</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">8290116</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="From2016-10-01to2017-03-31" unitRef="Shares" decimals="INF">3559749</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations contextRef="From2016-10-01to2017-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised contextRef="From2016-10-01to2017-03-31" unitRef="Shares" xsi:nil="true" />
    <ecpn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">8290116</ecpn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber>
    <ecpn:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice contextRef="AsOf2016-09-30" unitRef="UsdPerShare" decimals="INF">0.071</ecpn:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice>
    <ecpn:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice contextRef="AsOf2017-03-31" unitRef="UsdPerShare" decimals="INF">0.075</ecpn:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice>
    <ecpn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2017-03-31" unitRef="UsdPerShare" decimals="INF">0.075</ecpn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice>
    <dei:EntityRegistrantName contextRef="From2016-10-01to2017-03-31">EL CAPITAN PRECIOUS METALS INC</dei:EntityRegistrantName>
    <dei:TradingSymbol contextRef="From2016-10-01to2017-03-31">ecpn</dei:TradingSymbol>
    <dei:DocumentType contextRef="From2016-10-01to2017-03-31">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2016-10-01to2017-03-31">2017-03-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2016-10-01to2017-03-31">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2016-10-01to2017-03-31">0001135202</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="From2016-10-01to2017-03-31">--09-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityFilerCategory contextRef="From2016-10-01to2017-03-31">Smaller Reporting Company</dei:EntityFilerCategory>
    <dei:EntityCurrentReportingStatus contextRef="From2016-10-01to2017-03-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:DocumentFiscalYearFocus contextRef="From2016-10-01to2017-03-31">2017</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2016-10-01to2017-03-31">Q2</dei:DocumentFiscalPeriodFocus>
    <ecpn:InventoryConcentrate contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">146738</ecpn:InventoryConcentrate>
    <ecpn:InventoryConcentrate contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">150522</ecpn:InventoryConcentrate>
    <ecpn:InventoryIronOre contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">17888</ecpn:InventoryIronOre>
    <ecpn:InventoryIronOre contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">17888</ecpn:InventoryIronOre>
    <ecpn:PercentOfOutstandingCommonStockOfElCapitanDelawareOwnedByTheCompanyInPercent contextRef="AsOf2017-03-31" unitRef="Pure" decimals="INF">1.00</ecpn:PercentOfOutstandingCommonStockOfElCapitanDelawareOwnedByTheCompanyInPercent>
    <ecpn:PriorToJan192011PercentOfOutstandingCommonStockOfElCapitanLtdOwnedByElCapitanDelawareInPercent contextRef="AsOf2011-01-19" unitRef="Pure" decimals="INF">0.40</ecpn:PriorToJan192011PercentOfOutstandingCommonStockOfElCapitanLtdOwnedByElCapitanDelawareInPercent>
    <ecpn:PercentOfOutstandingCommonStockOfElCapitanLtdAcquiredByTheCompanyPursuantToTheGAmpMMergerInPercent contextRef="AsOf2011-01-19" unitRef="Pure" decimals="INF">0.60</ecpn:PercentOfOutstandingCommonStockOfElCapitanLtdAcquiredByTheCompanyPursuantToTheGAmpMMergerInPercent>
    <ecpn:PursuantToMergerEachShareOfGAmpMCommonAndPreferredStockOutstandingWasExchangedForApproximatelyTheNumberOfSharesOfCommonStockOfTheCompanyPerShare contextRef="AsOf2011-01-19" unitRef="UsdPerShare" decimals="INF">1.414156</ecpn:PursuantToMergerEachShareOfGAmpMCommonAndPreferredStockOutstandingWasExchangedForApproximatelyTheNumberOfSharesOfCommonStockOfTheCompanyPerShare>
    <ecpn:AggregateNumberOfSharesOfTheCompanySCommonStockIssuedToFormerGAmpMStockholders contextRef="AsOf2011-01-19" unitRef="Shares" decimals="INF">148127043</ecpn:AggregateNumberOfSharesOfTheCompanySCommonStockIssuedToFormerGAmpMStockholders>
    <ecpn:RecognizedStockBasedAdministrativeCompensationAggregating contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">0</ecpn:RecognizedStockBasedAdministrativeCompensationAggregating>
    <ecpn:RecognizedStockBasedAdministrativeCompensationAggregating contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">132358</ecpn:RecognizedStockBasedAdministrativeCompensationAggregating>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">384157</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2015-10-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2014-10-16to2014-10-17_custom_NoteAndWarrantPurchaseAgreementMember">2015-07-17</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2015-02-01to2015-02-04_us-gaap_UnsecuredDebtMember_custom_MriMember">2016-02-04</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2016-02-01to2016-02-04_us-gaap_UnsecuredDebtMember_custom_ConvesionAgreementMember_custom_MriMember">2017-02-04</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2017-02-01to2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember">2017-08-21</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2017-03-28to2017-03-29_us-gaap_UnsecuredDebtMember_custom_MriMember">2017-08-04</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2015-08-23to2015-08-24_custom_NoteAndWarrantPurchaseAgreementMember">2016-01-17</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2016-01-18to2016-01-19_custom_NoteAndWarrantPurchaseAgreementMember">2016-09-19</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2016-02-01to2016-02-04_us-gaap_UnsecuredDebtMember_custom_OneOfTheLendersAffiliatedWithTheCompanyMember">2017-02-08</us-gaap:DebtInstrumentMaturityDate>
    <ecpn:FutureIssuanceOfRestrictedSharesUnderTheNewAgreement contextRef="AsOf2016-01-05_custom_LogisticaNoteMember" unitRef="Shares" decimals="INF">10000000</ecpn:FutureIssuanceOfRestrictedSharesUnderTheNewAgreement>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="AsOf2017-03-31_custom_InsuranceFinancingAgreementMember" unitRef="USD" decimals="0">2853</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="AsOf2017-03-31_custom_InsuranceFinancingAgreementMember_us-gaap_OfficerMember" unitRef="USD" decimals="0">12743</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="AsOf2017-03-31_custom_LogisticaNoteMember" unitRef="USD" decimals="0">400000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="AsOf2017-03-31_us-gaap_UnsecuredDebtMember_custom_MriMember" unitRef="USD" decimals="0">68940</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="AsOf2017-03-31_custom_InsuranceFinancingAgreementMember_custom_FordFourFiftyTruckMember" unitRef="USD" decimals="0">25398</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2014-10-17_custom_NoteAndWarrantPurchaseAgreementMember" unitRef="Shares" decimals="INF">882352</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2015-08-24_custom_NoteAndWarrantPurchaseAgreementMember" unitRef="Shares" decimals="INF">4714286</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2016-01-19_custom_NoteAndWarrantPurchaseAgreementMember" unitRef="Shares" decimals="INF">471429</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="Shares" decimals="INF">602406</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2017-03-30_custom_InvestorAgreementMember" unitRef="Shares" decimals="INF">2707343</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2015-08-24_custom_NoteAndWarrantPurchaseAgreementMember" unitRef="UsdPerShare" decimals="INF">0.07</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2016-01-19_custom_NoteAndWarrantPurchaseAgreementMember" unitRef="UsdPerShare" decimals="INF">0.051</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-03-31_us-gaap_MinimumMember" unitRef="UsdPerShare" decimals="INF">0.051</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-03-31_us-gaap_MaximumMember" unitRef="UsdPerShare" decimals="INF">0.17</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-03-31_custom_ConvesionAgreementMember" unitRef="UsdPerShare" decimals="INF">0.08126</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="UsdPerShare" decimals="INF">0.3652</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-03-31_custom_ConversionAgreementMember" unitRef="UsdPerShare" decimals="INF">0.08126</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-03-30_custom_InvestorAgreementMember" unitRef="UsdPerShare" decimals="INF">0.08126</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2016-01-19_custom_NoteAndWarrantPurchaseAgreementMember" unitRef="USD" decimals="0">16775</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">93732</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2017-03-31_custom_ConvesionAgreementMember" unitRef="USD" decimals="0">16257</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2017-03-31_custom_ConversionAgreementMember" unitRef="USD" decimals="0">16257</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="USD" decimals="0">550000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-03-31_custom_InvestorAgreementMember" unitRef="USD" decimals="0">110000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:GeneralInsuranceExpense contextRef="From2015-08-01to2015-08-15_custom_InsuranceFinancingAgreementMember" unitRef="USD" decimals="0">28384</us-gaap:GeneralInsuranceExpense>
    <us-gaap:GeneralInsuranceExpense contextRef="From2016-11-01to2016-11-14_custom_InsuranceFinancingAgreementMember_us-gaap_OfficerMember" unitRef="USD" decimals="0">25224</us-gaap:GeneralInsuranceExpense>
    <us-gaap:GeneralInsuranceExpense contextRef="From2017-02-01to2017-02-23_custom_InsuranceFinancingAgreementMember_custom_FordFourFiftyTruckMember" unitRef="USD" decimals="0">26071</us-gaap:GeneralInsuranceExpense>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="From2015-08-01to2015-08-15_custom_InsuranceFinancingAgreementMember" unitRef="USD" decimals="0">2934</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="From2016-11-01to2016-11-14_custom_InsuranceFinancingAgreementMember_us-gaap_OfficerMember" unitRef="USD" decimals="0">2581</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="From2017-02-01to2017-02-23_custom_InsuranceFinancingAgreementMember_custom_FordFourFiftyTruckMember" unitRef="USD" decimals="0">781</us-gaap:DebtInstrumentPeriodicPayment>
    <ecpn:NotesPayableCurrentGross contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">858988</ecpn:NotesPayableCurrentGross>
    <ecpn:NotesPayableCurrentGross contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">454536</ecpn:NotesPayableCurrentGross>
    <ecpn:NotesPayableRelatedPartiesClassifiedCurrentGross contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">30000</ecpn:NotesPayableRelatedPartiesClassifiedCurrentGross>
    <ecpn:NotesPayableRelatedPartiesClassifiedCurrentGross contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">30000</ecpn:NotesPayableRelatedPartiesClassifiedCurrentGross>
    <ecpn:RelatedPartyDebtInstrumentUnamortizedDiscountCurrent contextRef="AsOf2016-09-30" unitRef="USD" xsi:nil="true" />
    <ecpn:RelatedPartyDebtInstrumentUnamortizedDiscountCurrent contextRef="AsOf2017-03-31" unitRef="USD" xsi:nil="true" />
    <ecpn:NotesPayableTotalPrincipalAmount contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">888988</ecpn:NotesPayableTotalPrincipalAmount>
    <ecpn:NotesPayableTotalPrincipalAmount contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">594536</ecpn:NotesPayableTotalPrincipalAmount>
    <ecpn:NotesPayableTotalUnamortizedDiscountAmount contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">1769</ecpn:NotesPayableTotalUnamortizedDiscountAmount>
    <ecpn:NotesPayableTotalUnamortizedDiscountAmount contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">102426</ecpn:NotesPayableTotalUnamortizedDiscountAmount>
    <ecpn:NotesPayableTotalNetAmount contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">887219</ecpn:NotesPayableTotalNetAmount>
    <ecpn:NotesPayableTotalNetAmount contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">492110</ecpn:NotesPayableTotalNetAmount>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="I151008" unitRef="Shares" decimals="INF">15000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2017-03-31_custom_EquityIncentivePlan2015Member" unitRef="Shares" decimals="INF">75000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <ecpn:NumberOfSharesOfCommonStockAuthorizedForIssuancePursuantToThe2015PlanInShares contextRef="I151014" unitRef="Shares" decimals="INF">15000000</ecpn:NumberOfSharesOfCommonStockAuthorizedForIssuancePursuantToThe2015PlanInShares>
    <ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanInShares contextRef="I151215" unitRef="Shares" decimals="INF">15000000</ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanInShares>
    <ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanInShares contextRef="AsOf2016-08-04" unitRef="Shares" decimals="INF">28000000</ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanInShares>
    <ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanInShares contextRef="AsOf2016-04-22" unitRef="Shares" decimals="INF">23000000</ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanInShares>
    <ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanInShares contextRef="AsOf2016-10-31" unitRef="Shares" decimals="INF">50000000</ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanInShares>
    <ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanWasIncreasedPursuantToAmendmentNo1ToThe2015PlanInShares contextRef="I151215" unitRef="Shares" decimals="INF">23000000</ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanWasIncreasedPursuantToAmendmentNo1ToThe2015PlanInShares>
    <ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanWasIncreasedPursuantToAmendmentNo1ToThe2015PlanInShares contextRef="AsOf2016-08-04" unitRef="Shares" decimals="INF">50000000</ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanWasIncreasedPursuantToAmendmentNo1ToThe2015PlanInShares>
    <ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanWasIncreasedPursuantToAmendmentNo1ToThe2015PlanInShares contextRef="AsOf2016-04-22" unitRef="Shares" decimals="INF">28000000</ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanWasIncreasedPursuantToAmendmentNo1ToThe2015PlanInShares>
    <ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanWasIncreasedPursuantToAmendmentNo1ToThe2015PlanInShares contextRef="AsOf2016-10-31" unitRef="Shares" decimals="INF">75000000</ecpn:NumberOfSharesOfCommonStockIssuableUnderThe2015PlanWasIncreasedPursuantToAmendmentNo1ToThe2015PlanInShares>
    <ecpn:NumberOfAdditionalSharesOfCommonStockAuthorizedForIssuancePursuantToThe2015PlanInShares contextRef="I160114" unitRef="Shares" decimals="INF">8000000</ecpn:NumberOfAdditionalSharesOfCommonStockAuthorizedForIssuancePursuantToThe2015PlanInShares>
    <ecpn:NumberOfAdditionalSharesOfCommonStockAuthorizedForIssuancePursuantToThe2015PlanInShares contextRef="AsOf2016-08-08" unitRef="Shares" decimals="INF">22000000</ecpn:NumberOfAdditionalSharesOfCommonStockAuthorizedForIssuancePursuantToThe2015PlanInShares>
    <ecpn:NumberOfAdditionalSharesOfCommonStockAuthorizedForIssuancePursuantToThe2015PlanInShares contextRef="AsOf2016-04-27" unitRef="Shares" decimals="INF">5000000</ecpn:NumberOfAdditionalSharesOfCommonStockAuthorizedForIssuancePursuantToThe2015PlanInShares>
    <ecpn:NumberOfAdditionalSharesOfCommonStockAuthorizedForIssuancePursuantToThe2015PlanInShares contextRef="AsOf2016-11-04" unitRef="Shares" decimals="INF">25000000</ecpn:NumberOfAdditionalSharesOfCommonStockAuthorizedForIssuancePursuantToThe2015PlanInShares>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="From2016-10-01to2017-03-31_us-gaap_OfficerMember" unitRef="Shares" decimals="INF">6097562</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="From2016-10-01to2017-03-31_us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" unitRef="Shares" decimals="INF">2774513</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2016-10-01to2017-03-31_custom_ContractMinersMember" unitRef="Shares" decimals="INF">7800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2017-01-01to2017-03-31_custom_PurchaseAgreementWithL2CapitalMember" unitRef="Shares" decimals="INF">3307382</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2016-10-01to2017-03-31_us-gaap_RestrictedStockMember_custom_AccruedLegalFeesMember" unitRef="Shares" decimals="INF">2744513</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2016-10-01to2017-03-31_custom_S8CommonStockMember_custom_AccruedLegalFeesMember" unitRef="Shares" decimals="INF">3000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2016-10-01to2017-03-31_custom_ContractMinersMember" unitRef="USD" decimals="0">562200</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2017-01-01to2017-03-31_custom_PurchaseAgreementWithL2CapitalMember" unitRef="USD" decimals="0">134323</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="From2016-10-01to2017-03-31_custom_ContractMinersMember" unitRef="USD" decimals="0">3784</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <ecpn:StockIssuedDuringPeriodValuePurchaseOfLabEquipment contextRef="From2016-10-01to2017-03-31_custom_ContractMinersMember" unitRef="USD" decimals="0">8515</ecpn:StockIssuedDuringPeriodValuePurchaseOfLabEquipment>
    <ecpn:StockIssuedDuringPeriodValueIssuedForPrepaymentOfServices contextRef="From2016-10-01to2017-03-31_custom_ContractMinersMember" unitRef="USD" decimals="0">322284</ecpn:StockIssuedDuringPeriodValueIssuedForPrepaymentOfServices>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2016-10-01to2017-03-31" unitRef="UsdPerShare" decimals="INF">0.042</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2016-10-01to2017-03-31" unitRef="UsdPerShare" decimals="INF">1.02</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2016-10-01to2017-03-31">P4Y4M13D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">24875</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2017-03-31_custom_EquityIncentivePlan2015Member" unitRef="Shares" decimals="INF">14438999</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <ecpn:RemainingWeightedAverageWarrantLife contextRef="From2016-10-01to2017-03-31">P1Y11M9D</ecpn:RemainingWeightedAverageWarrantLife>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2016-09-30_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" unitRef="USD" xsi:nil="true" />
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2016-09-30_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" unitRef="USD" xsi:nil="true" />
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2016-09-30_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" unitRef="USD" decimals="0">1864608</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2016-09-30_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="0">1864608</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2017-03-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" unitRef="USD" xsi:nil="true" />
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2017-03-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" unitRef="USD" xsi:nil="true" />
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2017-03-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" unitRef="USD" decimals="0">1864608</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2017-03-31_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="0">1864608</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2016-09-30_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" unitRef="USD" xsi:nil="true" />
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2016-09-30_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" unitRef="USD" xsi:nil="true" />
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2016-09-30_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" unitRef="USD" xsi:nil="true" />
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2016-09-30_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2017-03-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel1Member" unitRef="USD" xsi:nil="true" />
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2017-03-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel2Member" unitRef="USD" xsi:nil="true" />
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2017-03-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FairValueInputsLevel3Member" unitRef="USD" decimals="0">311652</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2017-03-31_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="0">311652</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2017-03-31_us-gaap_ConvertibleDebtMember" unitRef="USD" decimals="0">46559</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2017-03-31_us-gaap_WarrantMember" unitRef="USD" decimals="0">265094</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ExplorationExpenseMining contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">496829</us-gaap:ExplorationExpenseMining>
    <us-gaap:ExplorationExpenseMining contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">307179</us-gaap:ExplorationExpenseMining>
    <us-gaap:ExplorationExpenseMining contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">81691</us-gaap:ExplorationExpenseMining>
    <us-gaap:ExplorationExpenseMining contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">184205</us-gaap:ExplorationExpenseMining>
    <ecpn:LegalAndAccountingFees contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">69349</ecpn:LegalAndAccountingFees>
    <ecpn:LegalAndAccountingFees contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">45226</ecpn:LegalAndAccountingFees>
    <ecpn:LegalAndAccountingFees contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">66012</ecpn:LegalAndAccountingFees>
    <ecpn:LegalAndAccountingFees contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">144360</ecpn:LegalAndAccountingFees>
    <ecpn:WarrantAndOptionExpense contextRef="From2016-10-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <ecpn:WarrantAndOptionExpense contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">22367</ecpn:WarrantAndOptionExpense>
    <ecpn:AccruedCompensationRelatedPartiesCurrent contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">33983</ecpn:AccruedCompensationRelatedPartiesCurrent>
    <ecpn:AccruedCompensationRelatedPartiesCurrent contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">222186</ecpn:AccruedCompensationRelatedPartiesCurrent>
    <ecpn:CommonStockIssuedForRelatedPartyPayables contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">500000</ecpn:CommonStockIssuedForRelatedPartyPayables>
    <ecpn:CommonStockIssuedForRelatedPartyPayables contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">102849</ecpn:CommonStockIssuedForRelatedPartyPayables>
    <ecpn:CommonStockIssuedForPrepaymentOfServicesAndCosts contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">38804</ecpn:CommonStockIssuedForPrepaymentOfServicesAndCosts>
    <ecpn:CommonStockIssuedForPrepaymentOfServicesAndCosts contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">200130</ecpn:CommonStockIssuedForPrepaymentOfServicesAndCosts>
    <ecpn:CommonStockIssuedForFixedAssets contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">8515</ecpn:CommonStockIssuedForFixedAssets>
    <ecpn:CommonStockIssuedForFixedAssets contextRef="From2015-10-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsToAcquireFurnitureAndFixtures contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">16904</us-gaap:PaymentsToAcquireFurnitureAndFixtures>
    <us-gaap:PaymentsToAcquireFurnitureAndFixtures contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">787</us-gaap:PaymentsToAcquireFurnitureAndFixtures>
    <ecpn:CommonStockIssuedForEquipment contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">322284</ecpn:CommonStockIssuedForEquipment>
    <ecpn:CommonStockIssuedForEquipment contextRef="From2015-10-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2015-02-04_us-gaap_UnsecuredDebtMember_custom_MriMember" unitRef="USD" decimals="0">21211</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">102426</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="USD" decimals="0">88329</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">577883</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">588026</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetsCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">684281</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">891769</us-gaap:AssetsCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">252466</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">256250</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">135196</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">175921</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="AsOf2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ReceivablesNetCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">435400</us-gaap:ReceivablesNetCurrent>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">296619</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">24198</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:MineralPropertiesNet contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">1864608</us-gaap:MineralPropertiesNet>
    <us-gaap:MineralPropertiesNet contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">1864608</us-gaap:MineralPropertiesNet>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">74504</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">79857</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">22440</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">22440</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">3223716</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">3446700</us-gaap:Assets>
    <us-gaap:PreferredStockValue contextRef="AsOf2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2017-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommonStockValue contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">366255</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">403746</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">212865439</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">215445464</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">-212026608</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">-213720684</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">1205086</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">2128526</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">3223716</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">3446700</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">224079</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">296714</us-gaap:AccountsPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">857219</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">454536</us-gaap:NotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">7574</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">30000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">30000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">407332</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">158317</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:DerivativeLiabilities contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">311652</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">2018630</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">1301071</us-gaap:LiabilitiesCurrent>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2016-10-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2017-01-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2016-01-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2015-10-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">-1694076</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">-1246065</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">-174814</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">-729612</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2015-10-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">100000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">321800</us-gaap:ProceedsFromConvertibleDebt>
    <ecpn:ReclassificationOfAccruedInterestToPrincipalOutstanding contextRef="From2016-10-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <ecpn:ReclassificationOfAccruedInterestToPrincipalOutstanding contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">5940</ecpn:ReclassificationOfAccruedInterestToPrincipalOutstanding>
    <ecpn:ReclassificationOfWarrantsFromDerivativeLiabilitiesToEquity contextRef="From2016-10-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <ecpn:ReclassificationOfWarrantsFromDerivativeLiabilitiesToEquity contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">142803</ecpn:ReclassificationOfWarrantsFromDerivativeLiabilitiesToEquity>
    <ecpn:ConvertibleDebtIssuedForDeferredStockIssuanceCosts contextRef="From2016-10-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <ecpn:ConvertibleDebtIssuedForDeferredStockIssuanceCosts contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">35000</ecpn:ConvertibleDebtIssuedForDeferredStockIssuanceCosts>
    <us-gaap:Liabilities contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">2018630</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">1318174</us-gaap:Liabilities>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">26071</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="From2015-10-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">11671</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="From2015-10-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">8295</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermNotesPayable contextRef="AsOf2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermNotesPayable contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">17103</us-gaap:LongTermNotesPayable>
    <ecpn:ConvertibleNotesPayablePrincipalAmount contextRef="AsOf2016-09-30" unitRef="USD" xsi:nil="true" />
    <ecpn:ConvertibleNotesPayablePrincipalAmount contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">110000</ecpn:ConvertibleNotesPayablePrincipalAmount>
    <ecpn:ConvertibleNotesPayableUnamortizedDiscountAmount contextRef="AsOf2016-09-30" unitRef="USD" xsi:nil="true" />
    <ecpn:ConvertibleNotesPayableUnamortizedDiscountAmount contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">102426</ecpn:ConvertibleNotesPayableUnamortizedDiscountAmount>
    <ecpn:RelatedPartyNotesPayableNetAmount contextRef="AsOf2016-09-30" unitRef="USD" xsi:nil="true" />
    <ecpn:RelatedPartyNotesPayableNetAmount contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">7574</ecpn:RelatedPartyNotesPayableNetAmount>
    <ecpn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2016-10-01to2017-03-31" unitRef="UsdPerShare" decimals="INF">.129</ecpn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <ecpn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice contextRef="From2016-10-01to2017-03-31" unitRef="UsdPerShare" decimals="INF">.365</ecpn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;NOTE 1&amp;#160;&amp;#8211; BASIS OF PRESENTATION&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Business, Operations and Organization&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The accompanying unaudited interim financial statements of El Capitan Precious Metals, Inc. (&amp;#8220;El Capitan&amp;#8221; or the &amp;#8220;Company&amp;#8221;) have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) for interim financial information. Accordingly, the financial statements do not include all information and footnotes required by generally accepted accounting principles in the United States (&amp;#8220;GAAP&amp;#8221;) for complete annual financial statements. In the opinion of management, the accompanying unaudited interim financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation. Interim operating results are not necessarily indicative of results that may be expected for the fiscal year ending September&amp;#160;30, 2017, or for any subsequent period. These interim financial statements should be read in conjunction with the Company&amp;#8217;s audited financial statements and notes thereto for the fiscal year ended September 30, 2016, included in the Company&amp;#8217;s Annual Report on Form 10-K, filed with the SEC on&amp;#160;January 13, 2017 (the &amp;#8220;2016 Form 10-K&amp;#8221;). The consolidated balance sheet at September 30, 2016, has been derived from the audited financial statements included in the 2016 Form 10-K.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for fiscal 2016 as reported in the 2016 Form 10-K have been omitted.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;On July 26, 2002, El Capitan Precious Metals, Inc. was incorporated as a Delaware corporation to engage in the business of acquiring properties containing precious metals, principally gold, silver, and platinum (&amp;#8220;El Capitan Delaware&amp;#8221;). On March 18, 2003, El Capitan Delaware entered into a share exchange agreement with DML Services, Inc. (&amp;#8220;DML&amp;#8221;), a Nevada corporation, and became the wholly owned subsidiary of DML. On April 11, 2003, DML changed its name to El Capitan Precious Metals, Inc. The results of El Capitan Precious Metals, Inc., a Nevada corporation (formerly DML Services, Inc.), and its wholly owned Delaware subsidiary of the same name are presented on a consolidated basis.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;El Capitan Precious Metals, Inc., a Nevada corporation,&amp;#160;is based in Prescott, Arizona. Together with its consolidated subsidiaries (collectively referred to as the &amp;#8220;Company,&amp;#8221; &amp;#8220;our&amp;#8221; or &amp;#8220;we&amp;#8221;), the Company is an exploration stage company as defined by the Securities and Exchange Commission&amp;#8217;s (&amp;#8220;SEC&amp;#8221;) Industry Guide 7, as the Company has no established reserves as required under the Industry Guide 7. We are principally engaged in the exploration of precious metals and other minerals. Our primary asset is the 100% equity interest in El Capitan, Ltd., an Arizona corporation (&amp;#8220;ECL&amp;#8221;), which holds an interest in the El Capitan property located near Capitan, New Mexico (the &amp;#8220;El Capitan Property&amp;#8221;).&amp;#160;Our ultimate objective is to market and sell the El Capitan Property to a major mining company or enter into a joint venture arrangement with a major mining company to conduct mining operations. We have completed research and confirmation procedures on the recovery process for the El Capitan Property mineralized material and our evaluation as to the economic and legal feasibility of the property. We have not yet demonstrated the existence of proven or probable reserves at the El Capitan Property. To date, we have not had any material revenue producing operations.&amp;#160;&amp;#160;There is no assurance that a commercially viable mineral deposit exists on our property.&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;We commenced planned mineral exploration activity in the quarter ended December 2015 under our modified mining permit. However, we have not yet demonstrated the existence of proven or probable reserves at our El Capitan Property.&amp;#160;&amp;#160;As a result, and in accordance with accounting principles generally accepted in the United States for exploration stage companies, all expenditures for exploration and evaluation of our property are expensed as incurred.&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company owns&#13;100% of the outstanding common stock of El Capitan Delaware. Prior to January 19, 2011, El Capitan Delaware owned a 40% interest&#13;in El Capitan, Ltd., an Arizona corporation (&amp;#8220;ECL&amp;#8221;).&amp;#160;&amp;#160;On January 19, 2011, we acquired the remaining 60%&#13;interest in ECL from Gold and Minerals Company, Inc. (&amp;#8220;G&amp;#38;M&amp;#8221;) by merging an acquisition subsidiary created by the&#13;Company with and into G&amp;#38;M. In connection with the merger, each share of G&amp;#38;M common and preferred stock outstanding was&#13;exchanged for approximately 1.414156&amp;#160;shares&amp;#160;of the Company&amp;#8217;s common stock, resulting in the issuance of an aggregate&#13;of 148,127,043 shares of the Company&amp;#8217;s common stock to former G&amp;#38;M stockholders. Upon closing of the merger, G&amp;#38;M&#13;became a wholly-owned subsidiary of the Company and our consolidated Company acquired 100% of ECL. As a result, we now own 100%&#13;of the El Capitan Property site (described below).&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: justify"&gt;Principles of Consolidation&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries El Capitan Precious Metals, Inc., a Delaware corporation; Gold and Minerals Company, Inc., a Nevada corporation; and El Capitan, Ltd., an Arizona corporation. All significant inter-company accounts and transactions have been eliminated in consolidation.&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Reclassifications&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation.&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Basis of Presentation and Going Concern&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company's consolidated financial statements are prepared using the accrual method of accounting in accordance with accounting principles generally accepted in the United States of America ("GAAP"), and have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Company currently has a minimum source of revenue to cover its costs. The Company has incurred a loss for the year ended September 30, 2016 and for the six months ended March 31, 2017 and the Company has a working capital deficit as of March 31, 2017. These conditions raise substantial doubt about the Company&amp;#8217;s ability to continue as a going concern.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;To continue as a going concern, the Company is dependent on achievement of cash flow and future profits from entering the production stage of operations. The Company does not have adequate liquidity to fund its current operations, meet its obligations and continue as a going concern. The Company currently has an &amp;#8220;equity line&amp;#8221; financing arrangement under a Purchase Agreement with L2 Capital, LLC.&amp;#160; In the past the Company has secured working capital loans to assist in financing its activities for the near term. The Company may also pursue other financing alternatives from time to time, including short-term operational strategic financing or equity financing, to fund its activities until it can achieve cash flow and profits from its operations. The Company&amp;#8217;s consolidated financial statements do not include any adjustment relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence. &lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Fair Value of Financial Instruments&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The fair values of the Company&amp;#8217;s financial instruments, which include cash, investments, accounts payable, accrued expenses and notes payable, approximate their carrying amounts because of the short maturities of these instruments or because of restrictions.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Management Estimates and Assumptions&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The preparation of the Company&amp;#8217;s unaudited consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made; however, actual results could differ materially from these estimates.&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Cash and Cash Equivalents&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company considers&#13;those short-term, highly liquid investments with maturities of three months or less as cash and cash equivalents. At times, cash&#13;in banks may be in excess of the FDIC limits. The Company has no cash equivalents.&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Advances to Vendor&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company has made advances to the operator of a pilot plant which has been established to house equipment obtained from China that processes concentrates recovered at the El Capitan Property. The pilot plant, including the equipment, is owned by the operator of the pilot plant and not by the Company. The advances made by the Company are for site improvements, equipment and ancillary equipment required to attain the through put goal of management. The pilot plant is currently operational and generating concentrated product that is being shipped out to various refiners for processing and the Company is waiting for results from these refiners and any required specification requirements.&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The arrangements for repayment are included in the operating agreement with the operator. From proceeds of precious metal concentrates sales, all operating expenses incurred by each party for the period are reimbursed to the parties to the Agreement. The remaining profit for the period is divided equally and the plant operator from their profits must reimburse the Company for any advances made for equipment purchases and related modifications to equipment or the site.&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Inventory&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Inventories include mineralized material stockpile, concentrate, iron ore inventories and road base, as described below. Inventories are carried at the lower of average cost or net realizable value, in the case of mineralized material stockpile and concentrate inventories and minimal cost is attributable to the iron ore inventories. The net realizable value of mineralized material stockpile inventories represents the estimated future sales price of the product based on current and long-term metals prices, less the estimated costs to complete production and bring the product to sale. Concentrate inventories are carried at the lower of full cost of production or net realizable value based on current metals prices. Write-downs of inventory will be reported as a component of production costs applicable to sales.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;Mineralized Material&lt;/font&gt;&amp;#160;&lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;Stockpile Inventories&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Mineralized material stockpile inventories represent mineralized materials that have been mined and are available for further processing. Costs are allocated to mineralized material stockpile inventories based on relative values of material stockpiled and processed using current mining costs incurred up to the point of stockpiling the mineralized material.&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Concentrates&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Concentrates inventory include metal concentrates located either at the Company&amp;#8217;s El Capitan Property mine site or in transit to a customer&amp;#8217;s port. Inventories consist of mineralized material that contains gold and silver mineralization.&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Iron Ore&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Iron ore material is inventoried until the market prices are reestablished at a higher market demand and are valued at approximately $20 a ton. Any proceeds from the sale of iron ore will offset the cost of mining the mineralized ore.&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Property and Equipment&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Property and equipment are recorded at cost less accumulated depreciation. Upon retirement or sale, the cost of the assets disposed of and the related accumulated depreciation are removed from the accounts, with any resultant gain or loss being recognized as a component of operating income or expense. Depreciation is computed over the estimated useful lives of the assets using the straight-line method. Maintenance and repairs are charged to operations as incurred.&amp;#160;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Restricted Cash&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Restricted cash&#13;consists of two certificates of deposits in favor of the New Mexico Minerals and Mining Division for a total of $79,857. The amount&#13;is posted as a financial assurance for required reclamation work to be completed on mined and disturbed acreage.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Exploration Property Costs&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Exploration property costs are expensed as incurred until such time as economic reserves are quantified. To date the Company has not established any proven or probable reserves on the El Capitan Property. The Company has capitalized $1,864,608 of exploration property acquisition costs reflecting its investment in the El Capitan Property.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Derivative Financial Instruments&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company does not use derivative instruments to hedge exposures to cash flow or market risks. The Company reviews the terms of convertible debt, equity instruments and other financing arrangements to determine whether there are embedded derivative instruments, including embedded conversion options that are required to be bifurcated and accounted for separately as a derivative financial instrument. Also, in connection with the issuance of financing instruments, the Company may issue freestanding options or warrants that may, depending on their terms, be accounted for as derivative instrument liabilities, rather than as equity. The Company may also issue options or warrants to non-employees in connection with consulting or other services.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Derivative financial instruments are initially measured at their fair value. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income.  To the extent that the initial fair values of the freestanding and/or bifurcated derivative instrument liabilities exceed the total proceeds received, an immediate charge to income is recognized as a one day derivative loss, in order to initially record the derivative instrument liabilities at their fair value.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The discount from the face value of the convertible debt or equity instruments resulting from allocating some or all of the proceeds to the derivative instruments, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to income, using the effective interest method.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;When required to arrive at the fair value of derivatives associated with the convertible note and warrants, a Monte Carlo model was utilized that values the Convertible Note and Warrant based on average discounted cash flow factoring in the various potential outcomes by a Chartered Financial Analyst (&amp;#8216;CFA&amp;#8221;). In determining the fair value of the derivatives the CFA assumed that the Company&amp;#8217;s business would be conducted as a going concern.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is reassessed at the end of each reporting period. If reclassification is required, the fair value of the derivative instrument, as of the determination date, is reclassified. Any previous charges or credits to income for changes in the fair value of the derivative instrument are not reversed. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: justify"&gt;Stock-Based Compensation&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;FASB ASC 718 requires&#13;companies to measure all stock compensation awards using a fair value method and recognize the related compensation cost in its&#13;financial statements. Beginning with the Company&amp;#8217;s quarterly period that began on October 1, 2006, the Company adopted the&#13;provisions of FASB ASC 718 and expenses the fair value of employee stock options and similar awards in the financial statements.&#13;The Company accounts for share-based payments in accordance with ASC 718, &lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;i&gt;Compensation&#13;- Stock Compensation&lt;/i&gt;&lt;/font&gt;, which requires all share-based payments to employees, including grants of employee stock options,&#13;to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9,&#13;&amp;#8220;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;i&gt;Measurement Objective &amp;#8211; Fair Value at&#13;Grant Date&lt;/i&gt;&lt;/font&gt;,&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;i&gt;&amp;#8221;&lt;/i&gt;&lt;/font&gt; the Company&#13;estimates the fair value of the award using the Black-Scholes option pricing model for valuation of the share-based payments.&#13;The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change&#13;over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. The simplified&#13;method is used to determine compensation expense since historical option exercise experience is limited relative to the number&#13;of options issued. The compensation cost is recognized ratably using the straight-line method over the expected vesting period.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company accounts for stock-based compensation to other than employees in accordance with FASB ASC 505-50. Equity instruments issued to other than employees are valued at the earlier of a commitment date or upon completion of the services, based on the fair value of the equity instruments and is recognized as expense over the service period.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company recognized stock-based administrative compensation aggregating $-0- and $132,358 for common stock options and common stock issued to administrative personnel, directors and consultants during the six months ended March 31, 2017 and 2016, respectively.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;During the six month period ended March 31, 2017, the Company recognized stock compensation to our mine contractor of $206,813 and none for the comparable prior period of measurement. These costs incurred were attributable to the pilot plant operation and &lt;font style="font: 10pt Times New Roman, Times, serif; color: #000000"&gt;Mine Safety and Health Administration (&amp;#8220;MSHA&amp;#8221;)&lt;/font&gt; mine regulation consulting.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Revenue Recognition&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;When revenue is generated from operations, it will be recognized in accordance with FASB ASC 605. In general, the Company will recognize revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered, (iii) the fee is fixed or determinable, and (iv) collectability is reasonably assured. Revenue generated and costs incurred under this agreement will be reported on a net basis in accordance with FASB ASC 605-45. There was no revenue generated for the Company&amp;#8217;s quarters ended March 31, 2017 and 2016, respectively.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Recently Issued Accounting Pronouncements&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Other than as set forth below, management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;In January 2016, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;)&amp;#160; 2016-01, &lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;&amp;#8220;Financial Instruments - Recognition and Measurement of Financial Assets and Financial Liabilities (Subtopic 825-10).&amp;#8221;&lt;/font&gt; The amendments require all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under the equity method of accounting or those that result in consolidation of the investee). The amendments also require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments. In addition, the amendments eliminate the requirement to disclose the fair value of financial instruments measured at amortized cost for entities that are not public business entities and the requirement to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet for public business entities. This guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not expect to early adopt this guidance and does not believe that the adoption of this guidance will have a material impact on its consolidated financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;In March 2016,&#13;the FASB issued ASU No. 2016-09, &amp;#8220;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;i&gt;Compensation&#13;- Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.&amp;#8221; &lt;/i&gt;&lt;/font&gt;ASU 2016-09 amends&#13;several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of&#13;awards as either equity or liabilities and classification on the statement of cash flows. ASU 2016-09 is effective for fiscal&#13;years beginning after December 15, 2016, including interim periods within those fiscal years. Early adoption is permitted any&#13;interim or annual period. If early adopted, an entity must adopt all of the amendments in the same period. The Company is currently&#13;evaluating the potential impact of the adoption of ASU 2016-09 on the Company's consolidated financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; color: #000000; text-align: left; text-indent: 36pt"&gt;In August, 2016, the FASB issued ASU No. 2016-15, &amp;#8220;&lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments&amp;#8221;&lt;/font&gt; (a consensus of the Emerging Issues Task Force). Effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2018, and interim periods within fiscal years beginning after December 15, 2019. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. An entity that elects early adoption must adopt all of the amendments in the same period.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC during the current reporting period did not, or are not believed by management to have a material impact on the Company&amp;#8217;s present or future consolidated financial statements.&lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: justify"&gt;NOTE 2 &amp;#8211; RELATED PARTY TRANSACTIONS&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: justify"&gt;Consulting Agreements&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Effective May 1, 2009, the Company has informal arrangements with an individual, who is currently an officer, pursuant to which such individual serves as support staff for the functioning of the home office and all related corporate activities and projects. The aggregate monthly payments under the informal arrangements are $6,667. There is no written agreement with this individual. At March 31, 2017 and September 30, 2016, this individual had accrued and unpaid compensation of $11,483 and $40,000, respectively, recorded in accrued compensation &amp;#8211; related parties. During the six months ended March 31, 2017, the Company issued 487,806 shares of restricted common stock and 487,806 shares of S-8 common stock to this individual for payment of accrued compensation of $40,000. The fair value of the stock was $86,732 and the Company recorded a loss on extinguishment of debt of $46,732.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;During the six months ended March 31, 2017, the Company issued 1,768,293 shares of restricted common stock and 1,768,293 shares of S-8 common stock to a former officer and currently a director of the Company as payment of accrued compensation of $145,000. The fair value of the stock was $199,110 and the Company recorded a loss on extinguishment of debt of $54,110.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;In January 2012, the Company retained the consulting services of Management Resource Initiatives, Inc. (&amp;#8220;MRI&amp;#8221;), a company controlled by John F. Stapleton who served as the Chief Financial Officer and a director of the Company at that time and who currently serves as President and Chief Executive Officer and a director of the Company. The current monthly consulting fee for such services is $15,000. Total consulting fees expensed to MRI for both the six months ended March 31, 2017 and 2016 was $90,000, respectively. At March 31, 2017 and September 30, 2016, this individual had accrued and unpaid compensation of $22,500 and $315,000, respectively, recorded in accrued compensation &amp;#8211; related parties.&amp;#160;During the six months ended March 31, 2017, the Company issued 3,841,463 shares of restricted common stock and 3,841,463 shares of S-8 common stock to a this individual as payment of accrued compensation of $315,000. The fair value of the stock was $599,268 and the Company recorded a loss on extinguishment of debt of $284,268.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Total administrative consulting fees expensed under these informal arrangements for both the six months ended March 31, 2017 and 2016 was $130,000, respectively.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;On February 4,&#13;2015, the Company signed a $30,000 promissory note payable to MRI, at 18% interest per annum, due and payable on February 4, 2016.&#13;As an inducement for the loan represented by the note, the Company issued 200,000 shares of restricted common stock of the Company&#13;to MRI. The shares as of the date of this report have not been issued. The Company approved amending the note to extend the maturity&#13;date from February 4, 2016 to February 4, 2017 under the original terms of the Agreement. On March 29, 2017, the Company extended&#13;the note for six months to August 4, 2017.&amp;#160; See &lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;b&gt;&lt;i&gt;Note&#13;5 &amp;#8211; Notes Payable, February 4, 2015 Unsecured Promissory Notes.&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;NOTE 3 &amp;#8211; INVENTORY&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;The following table provides the components of inventory as of March 31, 2017 and September 30, 2016:&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="z1774afb50b0a4d6382f50f085ff7c75b" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 80%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;March 31,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;September 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Mineralized material stockpile&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;87,840&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;87,840&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Concentrate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;150,522&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;146,738&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Iron ore&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;17,888&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;17,888&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;256,250&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;252,466&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;NOTE 4 &amp;#8211; ACCRUED LIABILITIES&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 36pt"&gt;Accrued liabilities consisted of the following as of March 31, 2017 and September 30, 2016:&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;table id="z9d0d3e0f05f44489a493f52eb9466785" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 80%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;March 31,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;September 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Mining costs&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;60,613&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Accounting and legal&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;83,309&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;285,025&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Interest&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;75,008&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;61,694&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;158,317&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;407,332&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="clear: both"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;During the six months ended March 31, 2017, the Company issued 2,744,513 shares of restricted common stock and 3,000,000 shares of S-8 common stock as payment of accrued legal fees of $236,755. The fair value of the stock was $485,554 and the Company recorded a loss on extinguishment of debt of $248,799.&lt;/div&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;NOTE 5 &amp;#8211; NOTES PAYABLE&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic bold 10pt Times New Roman, Times, serif; text-align: justify"&gt;Agreements with Logistica U.S. Terminals, LLC&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Under an agreement with Logistica U.S. Terminals, LLC (&amp;#8220;Logistica&amp;#8221;) dated February 28, 2014, Logistica agreed to remit a $400,000 payment on the Company&amp;#8217;s behalf that represented the remaining balance of the Company&amp;#8217;s purchase price for a heavy ore trailing separation line to be used for processing of mineralized material at the El Capitan Property mine site. The Company previously remitted $100,000 toward the purchase of such equipment. In consideration for Logistica remitting such payment, the Company agreed to deliver a $400,000 promissory note to Logistica and issued 2,500,000 shares of common stock to a designee of Logistica under the Company&amp;#8217;s 2005 Stock Incentive Plan. The promissory note accrues interest at 4.5%, with principal and accrued interest payments to be made out of the Company&amp;#8217;s proceeds from sale of iron extracted from mineralized material as part of the Company&amp;#8217;s exploration activities. As of March 31, 2017, the outstanding balance under this note payable was $400,000 and accrued interest on the note was $55,578.&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 40pt"&gt;On January 5,&#13;2016, we entered into our current agreement with Logistica U.S. Terminals, LLC (&amp;#8220;Logistica&amp;#8221;). Under the agreement&#13;we will provide to Logistica concentrated ore to their specifications at the mine site. Logistica will transport, process, and&#13;refine the precious metals concentrates to sell to precious metals buyers. The terms of the agreement provide for the recovery&#13;of hard costs related to the concentrates by both parties prior to the distribution of profits. The agreement also provided for&#13;the issuance of 10,000,000 shares of our restricted common stock and the elimination of a $100,000 accrued liability to Logistica&#13;for prior services rendered. When certain terms and conditions are met, the Agreement calls for Logistica to arrange for a letter&#13;of credit for working capital for the mining, processing and sale activities under the Agreement. The shares were issued in August&#13;2016. The agreement superseded previous agreements between the Company and Logistica.&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic bold 10pt Times New Roman, Times, serif; text-align: left"&gt;October 17, 2014 Note and Warrant Purchase Agreement&lt;/div&gt;&#13;&#13;&lt;div style="font: italic bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;On October 17, 2014, we entered into a private Note and Warrant Purchase Agreement with an accredited investor pursuant to which we borrowed $500,000 against delivery of a promissory note (the &amp;#8220;2014 Note&amp;#8221;) in such amount and issued warrants to purchase 882,352 shares of our common stock. The promissory note carries an interest rate of 8% per annum, was initially due on July 17, 2015 and is secured by a first priority security interest in all right, title and interest of the Company in and to the net proceeds received by the Company from its sale of tailings separated from iron recovered by the Company at the El Capitan Property. On August 24, 2015, the maturity date of the 2014 Note was mutually extended to January 17, 2016. In consideration of the extension, the Company amended the common stock purchase warrant to purchase 4,714,286 shares (subject to adjustment) of our common stock at an exercise price of $0.07 per share. The warrant issued October 17, 2014 for 882,352 shares was cancelled. On January 19, 2016, the maturity date of the 2014 Note was further extended to September 19, 2016. The note was in default. In consideration of the extension, we issued to the investor a fully vested three year common stock purchase warrant to purchase 471,429 shares (subject to adjustment) of common stock of the Company at an exercise price of $0.051 per share, the closing price on the date of the agreed extension agreement. The fair value of the warrants was determined to be $16,775 using Black-Scholes option price model and was expensed during the three months ended March 31, 2016. The Note was delinquent and principal payments of $100,000 were made on the Note. During the six months ended March 31, 2017, the outstanding principal balance of the amended 2014 Note was reduced $150,000 and related accrued interest payments of $6,115 have been made.&amp;#160; On March 29, 2017, the Company authorized outstanding principal and accrued interest under the 2014 Note as of March 29, 2017 to be converted into common stock at the conversion price of $0.08126 per share. The parties entered into a conversion agreement dated March 31, 2017. The outstanding principal balance and accrued interest under the 2014 Note at the time of conversion were $250,000 and $6,027, respectively. The principal and accrued interest was converted into 3,150,719 shares of common stock at a fair market value of $266,236 and the Company recorded a loss on extinguishment of debt of $10,209. In connection with the conversion of the note payable on March 30, 2017, the Company issued a fully vested three year warrant to purchase 250,000 shares of common stock of the Company at an exercise price of $0.08126 per share. The fair value of the warrants was determined to be $16,257 using the Black-Scholes option pricing model and was expensed to the loss on conversion during the six months ended March 31, 2017.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic bold 10pt Times New Roman, Times, serif; text-align: left"&gt;February 4, 2015 Unsecured Promissory Notes&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;On February 4, 2015, we issued unsecured promissory notes in the aggregate principal amount of $63,000, of which a $30,000 note was issued to MRI, a company controlled by John F. Stapleton, who served as the Chief Financial Officer and a director of the Company at that time and who currently serves as President and Chief Executive Officer and a director of the Company. Outstanding amounts under these notes accrue interest at 18% per year, with all principal and accrued interest being due and payable on February 4, 2016. As additional consideration for the loan, we issued 200,000 shares of our restricted common stock for each note for a total of 400,000 shares. The relative fair value of the common stock was determined to be $21,211 and was recorded as discounts to the promissory notes was amortized to interest expense over the life of the notes. On February 4, 2016, one of the promissory notes was amended to extend the maturity date from February 4, 2016 to February 4, 2017 and reduced the interest rate to 10% per year. The Company also agreed to add the accrued interest on the note at February 4, 2016 of $5,940 to the principal of the note. In consideration of the amendment, the Company agreed to issue an aggregate 150,000 shares of restricted common stock of the Company to the lenders and the Board of Directors approved the issuance on April 22, 2016. One of the lenders is affiliated with the Company and provided $30,000 of the original $63,000 loaned funds and has agreed to extend the maturity date of the note to February 4, 2017 at the same rate of interest and the issuance of 200,000 shares of our restricted common stock. On March 29, 2017, the parties to the notes agreed to extend the maturity date of the notes for six months to August 4, 2017. Our obligations under both notes are personally guaranteed by a Company&amp;#8217;s director and who was the Chief Executive Officer at the time of the original notes.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;As of March 31,&#13;2017, the aggregate outstanding balance under these notes was $68,940, accrued interest was $16,120 and the unamortized discount&#13;on the notes payable was $-0-. During the six months ended March 31, 2017 and 2016, amortization expense of $1,769 and $8,976,&#13;respectively, was recognized.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Financing of Insurance Premiums and Vehicle&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;On August 15, 2016, we entered into an agreement to finance a portion of our liability insurance premiums in the amount of $28,384 at an interest rate of 7.25% with equal payments of $2,934, including interest, due monthly beginning July 14, 2016 and continuing through April 14, 2017. As of March 31, 2017, the outstanding balance under this note payable was $2,853.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;On November 14, 2016, we entered into an agreement to finance director and officer insurance premiums in the amount of $25,224 at an interest rate of 5% with equal payments of $2,581, including interest, due monthly beginning December 21, 2016 and continuing through September 21, 2017. As of March 31, 2017, the outstanding balance under this note payable was $12,743.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;On February 23, 2017, we entered into an agreement to finance a Ford 450 truck for transporting mineralized ore in the amount of $26,071 at an interest rate of 4.99% and 36 monthly payments of $781, due monthly beginning March 25, 2017, and continuing through February 25, 2020. As of March 31, 2017, the outstanding balance under this note payable was $25,398. The Chief Financial Officer co-signed on behalf of the Company on the finance contract.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic bold 10pt Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Convertible Note and Warrant Financing Transaction&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt Times New Roman, Times, serif; color: #000000; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; color: #000000; text-align: left; text-indent: 36pt"&gt;On February 21, 2017, we entered into a Securities Purchase Agreement (the &amp;#8220;Investor Agreement&amp;#8221;) pursuant to which the Company issued a convertible note (the &amp;#8220;Note&amp;#8221;) to an accredited investor in the aggregate principal amount of $550,000, or such lesser amounts based on actual advances thereunder. In order to reflect an agreed upon original issue discount, the outstanding principal amount of the Note attributable to each advance is 110% of the amount of the corresponding advance (&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;u&gt;i.e.&lt;/u&gt;&lt;/font&gt;, a $100,000 advance results in outstanding principal attributable to the advance of $110,000). Upon issuance of the Note, the investor made a $100,000 initial advance. The Company and the investor must mutually agree upon any future advances under the Note. Amounts advanced under the Note will accrue interest at 7% per annum. Except to the extent converted into common stock of the Company, as discussed below, outstanding principal and interest will become due and payable on August 21, 2017. Amounts outstanding under the Note are convertible at the election of the investor into common stock of the Company at a conversion price equal to $0.0913 (the volume weighted average price of the Company&amp;#8217;s common stock on the day prior to the issuance date). The Note provides for various events of default upon which amounts outstanding under the Note will immediately increase by 140% and the conversion price will be permanently redefined to equal 60% of the average of the three lowest traded prices during the 14 consecutive trading days preceding the conversion date. As additional consideration for the initial advance, the Company issued the investor a three year warrant to purchase up to 602,406 shares of the Company&amp;#8217;s common stock at an exercise price equal to $0.3652 per share (which price is subject to anti-dilution adjustment in the event the Company issues additional convertible securities with lower conversion prices). In conjunction with any future advances under the Note, the Company will issue additional three year warrants to purchase a number of shares equal to 50% of the conversion shares issuable upon conversion of the amount advanced. As of March 30, 2017, the warrant price was reset to $0.08126 and the number of warrants increased to 2,707,343.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;As set forth in&#13;the Statement of Financial Accounting Standard No. 820-10-35-37 &lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;i&gt;Fair&#13;Value in Financial Instruments &lt;/i&gt;&lt;/font&gt;to increase consistency, a fair value hierarchy was developed to rank the reliability&#13;of inputs that reflect assumptions, used as a basis for determining fair value. ASC 820 emphasizes that valuation techniques (income,&#13;market, and cost) used to measure the fair value of an asset or liability should maximize the use of observable inputs, that is,&#13;inputs that reflect the assumptions market participants would use in pricing the asset or liability developed based on market&#13;data obtained from sources independent of the reporting entity. The ASC 820 accounting standard requires companies use actual&#13;market data, when available or models, when unavailable. A quoted price in an active market provides the most reliable evidence&#13;of fair value and shall be used to measure fair value whenever available, except when it might not represent fair value at the&#13;measurement date. When using models, ASC 820 provides guidance on appropriate valuation techniques and addresses the inherent&#13;valuation issue of risk. A fair value measurement should include an adjustment for risk if market participants would include one&#13;in pricing the related asset or liability, even if the adjustment is difficult to determine.&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Convertible Notes and Warrants&#13;were analyzed in accordance with ASC 815. The objective of ASC 815 is to provide guidance for determining whether an&#13;equity-linked financial instrument is indexed to an entity&amp;#8217;s own stock. This determination is needed for a scope&#13;exception under Paragraph 11(a) of ASC 815 which would enable a derivative instrument to be accounted for under the accrual&#13;method. The classification of a non-derivative instrument that falls within the scope of ASC 815 also hinges on whether the&#13;instrument is indexed to an entity&amp;#8217;s own stock. A non-derivative instrument that is not indexed to an entity&amp;#8217;s&#13;own stock cannot be classified as equity and must be accounted for as a liability.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;To arrive at the fair value of derivatives associated with the convertible note and warrants, a Monte Carlo model was utilized that values the Convertible Note and Warrant based on average discounted cash flow of 500,000 iterations factoring in the various potential outcomes by a Chartered Financial Analyst (&amp;#8216;CFA&amp;#8221;). In determining the fair value of the derivatives the CFA assumed that the Company&amp;#8217;s business would be conducted as a going concern.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The fair value of the embedded&#13;derivatives on the note payable at inception was $71,635 and the derivative associated with the warrants at inception was&#13;$256,028. Derivatives aggregating at inception of $88,329 were allocated to loan discount and $239,334 was expensed as a  day&#13;one derivative loss. At March 31, 2017, the fair value of the embedded derivative on the note was $46,559 and the derivative&#13;on the warrants was $265,093. During the three months ended March 31, 2017, a net gain of $16,011 was recognized on the&#13;change in the fair value of the derivatives.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; color: #000000; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; color: #000000; text-align: left; text-indent: 36pt"&gt;The Investor Agreement contains covenants, representations and warranties of the Company and the investor that are typical for transactions of this type.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; color: #000000; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; color: #000000; text-align: left; text-indent: 36pt"&gt;The foregoing description of the terms of the Investor Agreement, Note and the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to the agreements and instruments themselves. The benefits and representations and warranties set forth in such agreements and instruments are not intended to and do not constitute continuing representations and warranties of the Company or any other party to persons not a party thereto.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;As of March 31, 2017, the aggregate outstanding principal balance under the note was $110,000, accrued interest was $823 and the unamortized discount on the note payable was $102,426. During the three months ended March 31, 2017, amortization of $7,574 was recognized as interest expense.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;The components of the notes payable, including the note payable to related party, at March 31, 2017 are as follows:&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;table id="z4d1a82ed1c9d4d72b029574eeba613b9" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 80%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Principal&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Unamortized&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Amount&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Discount&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Net&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Notes payable&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;454,536&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;454,536&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Convertible note payable&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;110,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;(102,426&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;7,574&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Notes payable &amp;#8211; related party&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;30,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;30,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;594,536&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;(102,426&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;492,110&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; clear: both; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;The components of the notes payable at September 30, 2016 are as follows:&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;table id="z1abaee433866418793c8f0057b098563" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 80%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Principal&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Unamortized&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Amount&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Discount&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Net&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Notes payable&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;858,988&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;(1,769&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;857,219&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Notes payable &amp;#8211; related party&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;30,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;30,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;888,988&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;(1,769&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;887,219&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: justify"&gt;NOTE 7 &amp;#8211; COMMITMENTS AND CONTINGENCIES&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Related Party&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;In January 2012, the Company retained the consulting services of Management Resource Initiatives, Inc. (&amp;#8220;MRI&amp;#8221;), a company controlled by John F. Stapleton who served as the Chief Financial Officer and a director of the Company at that time and who currently serves as President and Chief Executive Officer and a director of the Company. The current monthly consulting fee for such services is $15,000. Total consulting fees expensed to MRI for both the three months ended March 31, 2017 and 2016 was $45,000, respectively. At March 31, 2017, MRI had accrued and unpaid compensation of $22,500 recorded in accrued compensation &amp;#8211; related parties.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;On January 18, 2016, the Board of Directors of the Company appointed Stephan J. Antol as the Company&amp;#8217;s Chief Financial Officer, replacing Mr. Stapleton in such capacity. Mr. Stapleton continued to serve as a director of the Company and as Chairman of the Board. Effective August 4, 2016, the Board of Directors of the Company appointed Mr. Stapleton to replace Charles C. Mottley as President and Chief Executive Officer of the Company. The change in senior management was proposed by Mr. Mottley, who continues to serve as a member of the Company&amp;#8217;s Board of Directors and as President Emeritus. At March 31, 2017, Mr. Antol had accrued and unpaid compensation of $11,483 recorded in accrued compensation &amp;#8211; related parties.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;On February 4, 2015, the Company signed a $30,000 promissory note payable to MRI, at 18% interest per annum, due and payable on February 4, 2016. As an inducement for the loan represented by the note, the Company issued 200,000 shares of restricted common stock of the Company to MRI. The Company approved amending the note to extend the maturity date from February 4, 2016 to February 4, 2017 under the original terms of the Agreement and on March 29, 2017 the parties to the note extended the due date for six months to August 4, 2017. See&amp;#160;&lt;font style="font: italic bold 10pt Times New Roman, Times, serif"&gt;Note 5 &amp;#8211; Notes Payable, February 4, 2015 Unsecured Promissory Notes.&lt;/font&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; margin-left: 74.9pt; text-indent: -74.9pt"&gt;Purchase Contract with Glencore AG&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;On March 10, 2014,&#13;the Company entered into a life-of-mine off take agreement with Glencore AG (&amp;#8220;Glencore&amp;#8221;) for the sale of iron extracted&#13;from mineralized material at the El Capitan Property (such agreement is referred to herein as the &amp;#8220;Glencore Purchase Contract&amp;#8221;).&#13;Under the terms of the Glencore Purchase Contract, the Company agreed to sell to Glencore, and Glencore agreed to purchase from&#13;the Company, iron that meets the applicable specifications from the El Capitan Property mine. Payment for the iron is to be made&#13;pursuant an irrevocable letter of credit in favor of the Company. The purchase price is based on an index price less an applicable&#13;discount. Either party may terminate the Glencore Purchase Contract following a breach by the other party that remains uncured&#13;for a specified period after receipt of written notice. Because of current market iron ore prices, the contract has not been implemented&#13;or terminated.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Agreements with Logistica U.S. Terminals, LLC&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Under an agreement with Logistica U.S. Terminals, LLC (&amp;#8220;Logistica&amp;#8221;) dated February 28, 2014, Logistica agreed to remit a $400,000 payment on the Company&amp;#8217;s behalf that represented the remaining balance of the Company&amp;#8217;s purchase price for a heavy ore trailing separation line to be used for processing of mineralized material at the El Capitan Property mine site. The Company previously remitted $100,000 toward the purchase of such equipment. In consideration for Logistica remitting such payment, the Company agreed to deliver a $400,000 promissory note to Logistica and issued 2,500,000 shares of common stock to a designee of Logistica under the Company&amp;#8217;s 2005 Stock Incentive Plan. The promissory note accrues interest at 4.5%, with principal and accrued interest payments to be made out of the Company&amp;#8217;s proceeds from sale of iron extracted from mineralized material as part of the Company&amp;#8217;s exploration activities. As of March 31, 2017, the outstanding balance under this note payable was $400,000 and accrued interest on the note was $55,578.&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 40pt"&gt;On January 5, 2016, we entered into our current agreement with Logistica U.S. Terminals, LLC (&amp;#8220;Logistica&amp;#8221;). Under the agreement we will provide to Logistica concentrated ore to their specifications at the mine site. Logistica will transport, process, and refine the precious metals concentrates to sell to precious metals buyers. The terms of the new agreement provide for the recovery of hard costs related to the concentrates by both parties prior to the distribution of profits. The agreement also provides for the issuance of 10,000,000 shares of our restricted common stock and the elimination of a $100,000 accrued liability to Logistica for prior services rendered. When certain terms and conditions are met, the Agreement calls for Logistica to arrange for a letter of credit for working capital for the mining, processing and sale activities under the Agreement. The shares were issued in August 2016. The new agreement supersedes the previous agreements with Logistica.&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: justify"&gt;NOTE 8 &amp;#8211; 2015 EQUITY INCENTIVE PLAN&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; color: #000000; text-align: left; text-indent: 40pt"&gt;On October 8, 2015, the Board of Directors of the Company approved the El Capitan Precious Metals, Inc. 2015 Equity Incentive Plan (the &amp;#8220;2015 Plan&amp;#8221;). The 2015 Plan enables the Board of Directors to grant to employees, directors, and consultants of the Company and its subsidiaries a variety of forms of equity-based compensation, including grants of options to purchase shares of common stock, shares of restricted common stock, restricted stock units, stock appreciation rights, other stock-based awards and performance-based awards. At the time it was adopted, the maximum number of shares of common stock of the Company that could be issued or awarded under the 2015 Plan was 15,000,000 shares. On October 14, 2015, the Company filed Form S-8 Registration Statement No. 333-207399 with the SEC registering the 15,000,000 shares of common stock authorized for issuance pursuant to the 2015 Plan. On December 15, 2015, the Board of Directors of the Company adopted Amendment No. 1 to the 2015 Plan, pursuant to which the number of shares of common stock issuable under the 2015 Plan was increased from 15,000,000 to 23,000,000. On January 14, 2016, the Company filed Form S-8 Registration Statement No. 333-208991 with the SEC registering the additional 8,000,000 shares of common stock authorized for issuance pursuant to the 2015 Plan. Effective April 22, 2016, the Board of Directors of the Company adopted Amendment No. 2 to the 2015 Plan pursuant to which the number of shares of the common stock issuable under the 2015 Plan was increased from 23,000,000 to 28,000,000. On April 27, 2016, the Company filed Form S-8 Registration Statement No. 333-210942 with the SEC registering the additional 5,000,000 shares of common stock authorized for issuance pursuant to the 2015 Plan. Effective August 4, 2016, the Board of Directors of the Company adopted Amendment No. 3 to the 2015 Plan pursuant to which the number of shares of the common stock issuable under the 2015 Plan was increased from 28,000,000 to 50,000,000. On August 8, 2016, the Company filed Form S-8 Registration Statement No. 333- 212972 with the SEC registering the additional 22,000,000 shares of common stock authorized for issuance pursuant to the 2015 Plan. Effective October 31, 2016, the Board of Directors of the Company adopted Amendment No. 4 to the Company&amp;#8217;s 2015 Plan pursuant to which the number of shares of the common stock issuable under the 2015 Plan was increased from 50,000,000 to 75,000,000. On November&amp;#160;4, 2016, the Company filed Form S-8 Registration Statement No. 333- 214442 with the SEC registering the additional 25,000,000 shares of common stock authorized for issuance pursuant to the 2015 Plan.&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;NOTE 9&amp;#160;&amp;#8211; STOCKHOLDERS&amp;#8217; EQUITY&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Authorized Common Shares&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;At the Company&amp;#8217;s annual meeting of stockholders held September 28, 2016, the Company&amp;#8217;s stockholders approved an amendment (the &amp;#8220;Amendment&amp;#8221;) to the Company&amp;#8217;s Articles of Incorporation to increase the number of authorized shares of the Company&amp;#8217;s common stock from 400,000,000 to 500,000,000 shares.&amp;#160;The change in the authorized number of shares of common stock was effected pursuant to an Certificate of Amendment (the &amp;#8220;Certificate of Amendment&amp;#8221;) filed with the Secretary of State of the State of Nevada on October 4, 2016 and was effective as of such date.&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: justify"&gt;Preferred Stock Issuances&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;During the six months ended March 31, 2017, the Company did not issue any shares of preferred stock.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Equity Purchase Agreement&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Termination of River North Purchase Agreement; Entry into L2 Purchase Agreement&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company and River North Equity, LLC (&amp;#8220;River North&amp;#8221;) have been parties to an Equity Purchase Agreement dated March 16, 2016, as amended by Amendment No. 1 dated December 9, 2016 (as so amended, the &amp;#8220;River North Purchase Agreement&amp;#8221;). Under the River North Purchase Agreement, the Company had the right from time to time, in its discretion, to sell shares of its common stock to River North for aggregate gross proceeds of up to $5,000,000.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;On February 21, 2017, the Company and River North terminated the River North Purchase Agreement and a related registration rights agreement and the Company entered into a new Equity Purchase Agreement (the &amp;#8220;L2 Purchase Agreement&amp;#8221;) with L2 Capital, LLC (&amp;#8221;L2 Capital&amp;#8221;), an affiliate of River North. Under the L2 Purchase Agreement, the Company may from time to time, in its discretion, sell shares of its common stock to L2 Capital for aggregate gross proceeds of up to $5,000,000. Unless terminated earlier, L2 Capital&amp;#8217;s purchase commitment will automatically terminate on the earlier of the date on which L2 Capital shall have purchased Company shares pursuant to the Purchase Agreement for an aggregate purchase price of $5,000,000, or February 21, 2020. The Company has no obligation to sell any shares under the L2 Purchase Agreement.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;As provided in the L2 Purchase Agreement, the Company may require L2 Capital to purchase shares of common stock from time to time by delivering a put notice to L2 Capital specifying the total number of shares to be purchased (such number of shares multiplied by the purchase price described below, the &amp;#8220;Investment Amount&amp;#8221;); provided there must be a minimum of 10 trading days between delivery of each put notice. The Company may determine the Investment Amount, provided that such amount may not be more than the average daily trading volume in dollar amount for the Company&amp;#8217;s common stock during the 10 trading days preceding the date on which the Company delivers the applicable put notice. Additionally, such amount may not be lower than $5,000 or higher than $150,000. L2 Capital will have no obligation to purchase shares under the L2 Purchase Agreement to the extent that such purchase would cause L2 Capital to own more than 9.99% of the Company&amp;#8217;s common stock.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;For each share&#13;of the Company&amp;#8217;s common stock purchased under the L2 Purchase Agreement, L2 Capital will pay a purchase price equal to 85%&#13;of the Market Price, which is defined as the average of the two lowest closing bid prices on the OTCQB Marketplace, as reported&#13;by Bloomberg Finance L.P., during the five consecutive Trading Days including and immediately prior to the settlement date of&#13;the sale, which in most circumstances will be the trading day immediately following the &amp;#8220;Put Date,&amp;#8221; or the date that&#13;a put notice is delivered to L2 Capital (the &amp;#8220;Pricing Period&amp;#8221;). The purchase price will be adjusted as follows: (i)&#13;an additional 10% discount to the Market Price will be applied if either (A) the Closing Price of the Common Stock on the Put&#13;Date is less than $0.10 per share, or (B) the average daily trading volume in dollar amount for the Common Stock during the 10&#13;trading days including and immediately preceding the Put Date is less than $50,000; (ii) an additional 5% discount to the Market&#13;Price will be applied if the Company is not deposit/withdrawal at custodian (&amp;#8220;DWAC&amp;#8221;) eligible; and (iii) an additional&#13;10% discount to the Marker Price will be applied if the Company is under DTC &amp;#8220;chill&amp;#8221; status. L2 Capital&amp;#8217;s obligation&#13;to purchase shares on any settlement date is subject to customary closing conditions, including without limitation a requirement&#13;that a registration statement remain effective registering the resale by L2 Capital of the shares to be issued. The L2 Purchase&#13;Agreement is not transferable and any benefits attached thereto may not be assigned.&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The L2 Purchase Agreement contains covenants, representations and warranties of the Company and L2 Capital that are typical for transactions of this type. In addition, the Company and L2 Capital have granted each other customary indemnification rights in connection with the L2 Purchase Agreement. The L2 Purchase Agreement may be terminated by the Company at any time.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;In connection with the L2 Purchase Agreement, the Company also entered into Registration Rights Agreement with L2 Capital requiring the Company to prepare and file, within 45 days, a registration statement registering the resale by L2 Capital of shares to be issued under the L2 Purchase Agreement, to use commercially reasonable efforts to cause such registration statement to become effective, and to keep such registration statement effective until (i) three months after the last closing of a sale of shares under the L2 Purchase Agreement, (ii) the date when L2 Capital may sell all the shares under Rule 144 without volume limitations, or (iii) the date L2 Capital no longer owns any of the shares. The registration statement was filed on February 28, 2017 and declared effective on March 10, 2017.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The foregoing description of the terms of the Termination with River North and the L2 Purchase Agreement and corresponding Registration Rights Agreement does not purport to be complete and is subject to and qualified in its entirety by reference to the agreements themselves, copies of which are filed as Exhibits 10.4, 10.5 and 10.6, respectively, to our Current Report on Form 8-K filed with the SEC on February 23, 2017, and the terms of which are incorporated herein by reference. The benefits and representations and warranties set forth in such documents (if any) are not intended to and do not constitute continuing representations and warranties of the Company or any other party to persons not a party thereto.&lt;/div&gt;&#13;&#13;&lt;div style="font: italic bold 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Likelihood of Accessing the Full Amount of the Equity Line&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Notwithstanding that the Equity Line is in an amount of $5,000,000, we anticipate that the actual likelihood that we will be able access the full $5,000,000 may be low due to several factors, including that our ability to access the Equity Line is impacted by our average daily trading volume, the average computed sale price of the shares for each put, which may limit the maximum dollar amount of each put we deliver to L2 Capital. Our use of the Equity Line will continue to be limited and restricted if our share trading volume or market price of our stock continue at their current levels or decrease further in the future from the volume and stock prices reported over the past year.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Further, our ability to issue shares in excess of the 25,000,000 shares covered by the registration statement will be subject to our filing a subsequent registration statement with the SEC and the SEC declaring it effective.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font-weight: bold"&gt;Common Stock Issuances&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;During the six months ended March 31, 2017, the Company:&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left"&gt;&#13;&lt;table id="z04fe067655534acba348e62fee77478c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 31.5pt; vertical-align: top"&gt;(i)&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: left"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Issued 6,097,562 shares of restricted common stock and 6,097,562 shares of S-8 common stock for accrued compensation payable to three officers valued at $885,110 on the date of issuances and recorded a loss on debt extinguishment of $385,110;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left"&gt;&#13;&lt;table id="zbc468df1ce514a50aea58ecb9ac9ea9a" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 31.5pt; vertical-align: top"&gt;(ii)&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: left"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Issued 3,000,000 shares of S-8 common stock and 2,774,513 shares of restricted common stock for accrued legal services at a market value of $485,554 and recorded a loss on debt extinguishment of $248,799;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left"&gt;&#13;&lt;table id="zeeccd7bc3cb346ab99d3e102995efddf" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 31.5pt; vertical-align: top"&gt;(iii)&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: left"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Issued 7,800,000 shares of S-8 common stock to our contract miners at a market value of $562,200, including prepayment of $38,804 cost and services, payment of $3,784 for inventory, payment of $8,515 for lab equipment and an advance of $322,284 for pilot plant equipment costs and $188,813 for pilot plant operating costs and MSHA consulting;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left"&gt;&#13;&lt;table id="z901a794e9eab4c3c8f990e07da8fa6cc" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 31.5pt; vertical-align: top"&gt;(iv)&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: left"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Issued 7,684,671 shares of common stock under the 2016 Purchase Agreement with River North for aggregate cash proceeds of $344,576;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left"&gt;&#13;&lt;table id="z5d80a874c6904a96a4f17d4c06cfceb0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 31.5pt; vertical-align: top"&gt;(v)&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: left"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Issued 685,396 shares of common stock under the 2017 Purchase Agreement with L2 Capital for aggregate cash proceeds of $39,582;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left"&gt;&#13;&lt;table id="z111d71a14d274629ba72afc6d3f96bd1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 31.5pt; vertical-align: top"&gt;(vi)&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: left"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Issued 200,000 shares of S-8 common stock to a mine consultant at a market value of $18,000; and&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left"&gt;&#13;&lt;table id="z2b43a021ae3c4653bb952ffd90185e44" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 31.5pt; vertical-align: top"&gt;(vii)&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: left"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Issued 3,150,719 shares of common stock for the conversion of a note payable and accrued interest at a market value of $266,236 and recorded an on debt extinguishment of $10,209.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Options&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;During the six months ended March 31, 2017, the Company did not grant any options.&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: justify"&gt;Warrants&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;During six months ended March 31, 2017, the following transactions occurred with respect to warrants of the Company:&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left"&gt;&#13;&lt;table id="z6b48cac20ce74a02932469bae3a3304e" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 31.5pt; vertical-align: top"&gt;(i)&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: left"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;In connection with the conversion of a note payable on March 30, 2017, the Company issued a fully vested three year warrant to purchase 250,000 shares of common stock of the Company at an exercise price of $0.08126 per share. The fair value of the warrants was determined to be $16,257 using the Black-Scholes option pricing model and was expensed to the loss on conversion during the six months ended March 31, 2017.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left"&gt;&#13;&lt;table id="z5299470cceff425d8ef62233875f98cb" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 31.5pt; vertical-align: top"&gt;(ii)&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: left"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; color: #000000"&gt;Pursuant to the February 21, 2017 Securities Purchase Agreement with an accredited investor, the Company issued to the investor a three year warrant to purchase up to 602,406 shares of the Company&amp;#8217;s common stock at an exercise price equal to $0.3652 per share (which price is subject to anti-dilution adjustment in the event the Company issues additional convertible securities with lower conversion prices). As of March 30, 2017, the warrant price was reset to $0.08126 and the number of warrants increased to 2,707,343.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left"&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Stock option activity, both within and outside the 2015 Plan, and warrant activity for the six months ended March 31, 2017, are as follows:&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="z621164e3a2ae428bae97444a78f1e8c8" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 80%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Stock Options&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Stock Warrants&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Average&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Exercise&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Outstanding at September 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;11,137,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;0.265&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;5,332,773&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;0.071&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;3,559,749&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;.129&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Canceled&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;(602,406&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;.365&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Expired&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Exercised&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Outstanding at March 31, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;11,137,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;0.265&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;8,290,116&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;0.075&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Exercisable at March 31, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;11,137,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;0.265&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;8,290,116&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;0.075&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; clear: both; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The range of exercise prices and remaining weighted average life of the options outstanding at March 31, 2017 were $0.042 to $1.02 and 4.37 years, respectively. The aggregate intrinsic value of the outstanding options at March 31, 2017 was $24,875.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The range of exercise&#13;prices and remaining weighted average life of the warrants outstanding at March 31, 2017 were $0.051 to $0.17 and 1.94 years,&#13;respectively. The aggregate intrinsic value of the outstanding warrants at March 31, 2017 was $93,732.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company maintains its 2015 Equity Incentive Plan, as amended (the &amp;#8220;2015 Plan&amp;#8221;), pursuant to which the Company has reserved and registered 75,000,000 shares for stock and option grants. As of March 31, 2017, there were 14,438,999 shares available for grant under the 2015 Plan, excluding the 11,137,500 options outstanding.&lt;/div&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;NOTE 10 &amp;#8211; SUBSEQUENT EVENTS&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic bold 10pt Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Subsequent Issuances of Common Stock&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; color: #000000; text-align: left; text-indent: 40pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 40pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif; color: #000000"&gt;Subsequent to &lt;/font&gt;March 31, 2017&lt;font style="font: 10pt Times New Roman, Times, serif; color: #000000"&gt;, the Company issued 3,307,382 shares of common stock under the L2 Purchase Agreement with L2 Capital for aggregate cash proceeds of $134,323.&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic bold 10pt Times New Roman, Times, serif; color: #000000; text-align: left"&gt;Board Approval of Stock Issuances Subsequent to March 31, 2017&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; color: #000000; text-align: left; text-indent: 36pt"&gt;On March 29, 2017, the Board authorized the issuance of up to 3,000,000 S-8 common shares to our contract miner to meet current obligations for services currently being provided to the Company.&amp;#160; As of the date of filing this 10-Q, 2,700,000 have been advanced under this authorization.&lt;/div&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <ecpn:BusinessOperationsAndOrganizationTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Business, Operations and Organization&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The accompanying unaudited interim financial statements of El Capitan Precious Metals, Inc. (&amp;#8220;El Capitan&amp;#8221; or the &amp;#8220;Company&amp;#8221;) have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) for interim financial information. Accordingly, the financial statements do not include all information and footnotes required by generally accepted accounting principles in the United States (&amp;#8220;GAAP&amp;#8221;) for complete annual financial statements. In the opinion of management, the accompanying unaudited interim financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation. Interim operating results are not necessarily indicative of results that may be expected for the fiscal year ending September&amp;#160;30, 2017, or for any subsequent period. These interim financial statements should be read in conjunction with the Company&amp;#8217;s audited financial statements and notes thereto for the fiscal year ended September 30, 2016, included in the Company&amp;#8217;s Annual Report on Form 10-K, filed with the SEC on&amp;#160;January 13, 2017 (the &amp;#8220;2016 Form 10-K&amp;#8221;). The consolidated balance sheet at September 30, 2016, has been derived from the audited financial statements included in the 2016 Form 10-K.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for fiscal 2016 as reported in the 2016 Form 10-K have been omitted.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;On July 26, 2002, El Capitan Precious Metals, Inc. was incorporated as a Delaware corporation to engage in the business of acquiring properties containing precious metals, principally gold, silver, and platinum (&amp;#8220;El Capitan Delaware&amp;#8221;). On March 18, 2003, El Capitan Delaware entered into a share exchange agreement with DML Services, Inc. (&amp;#8220;DML&amp;#8221;), a Nevada corporation, and became the wholly owned subsidiary of DML. On April 11, 2003, DML changed its name to El Capitan Precious Metals, Inc. The results of El Capitan Precious Metals, Inc., a Nevada corporation (formerly DML Services, Inc.), and its wholly owned Delaware subsidiary of the same name are presented on a consolidated basis.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;El Capitan Precious Metals, Inc., a Nevada corporation,&amp;#160;is based in Prescott, Arizona. Together with its consolidated subsidiaries (collectively referred to as the &amp;#8220;Company,&amp;#8221; &amp;#8220;our&amp;#8221; or &amp;#8220;we&amp;#8221;), the Company is an exploration stage company as defined by the Securities and Exchange Commission&amp;#8217;s (&amp;#8220;SEC&amp;#8221;) Industry Guide 7, as the Company has no established reserves as required under the Industry Guide 7. We are principally engaged in the exploration of precious metals and other minerals. Our primary asset is the 100% equity interest in El Capitan, Ltd., an Arizona corporation (&amp;#8220;ECL&amp;#8221;), which holds an interest in the El Capitan property located near Capitan, New Mexico (the &amp;#8220;El Capitan Property&amp;#8221;).&amp;#160;Our ultimate objective is to market and sell the El Capitan Property to a major mining company or enter into a joint venture arrangement with a major mining company to conduct mining operations. We have completed research and confirmation procedures on the recovery process for the El Capitan Property mineralized material and our evaluation as to the economic and legal feasibility of the property. We have not yet demonstrated the existence of proven or probable reserves at the El Capitan Property. To date, we have not had any material revenue producing operations.&amp;#160;&amp;#160;There is no assurance that a commercially viable mineral deposit exists on our property.&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;We commenced planned mineral exploration activity in the quarter ended December 2015 under our modified mining permit. However, we have not yet demonstrated the existence of proven or probable reserves at our El Capitan Property.&amp;#160;&amp;#160;As a result, and in accordance with accounting principles generally accepted in the United States for exploration stage companies, all expenditures for exploration and evaluation of our property are expensed as incurred.&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company owns&#13;100% of the outstanding common stock of El Capitan Delaware. Prior to January 19, 2011, El Capitan Delaware owned a 40% interest&#13;in El Capitan, Ltd., an Arizona corporation (&amp;#8220;ECL&amp;#8221;).&amp;#160;&amp;#160;On January 19, 2011, we acquired the remaining 60%&#13;interest in ECL from Gold and Minerals Company, Inc. (&amp;#8220;G&amp;#38;M&amp;#8221;) by merging an acquisition subsidiary created by the&#13;Company with and into G&amp;#38;M. In connection with the merger, each share of G&amp;#38;M common and preferred stock outstanding was&#13;exchanged for approximately 1.414156&amp;#160;shares&amp;#160;of the Company&amp;#8217;s common stock, resulting in the issuance of an aggregate&#13;of 148,127,043 shares of the Company&amp;#8217;s common stock to former G&amp;#38;M stockholders. Upon closing of the merger, G&amp;#38;M&#13;became a wholly-owned subsidiary of the Company and our consolidated Company acquired 100% of ECL. As a result, we now own 100%&#13;of the El Capitan Property site (described below).&amp;#160;&lt;/div&gt;&lt;/div&gt;</ecpn:BusinessOperationsAndOrganizationTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: justify"&gt;Principles of Consolidation&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries El Capitan Precious Metals, Inc., a Delaware corporation; Gold and Minerals Company, Inc., a Nevada corporation; and El Capitan, Ltd., an Arizona corporation. All significant inter-company accounts and transactions have been eliminated in consolidation.&lt;/div&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Reclassifications&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation.&lt;/div&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Basis of Presentation and Going Concern&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company's consolidated financial statements are prepared using the accrual method of accounting in accordance with accounting principles generally accepted in the United States of America ("GAAP"), and have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Company currently has a minimum source of revenue to cover its costs. The Company has incurred a loss for the year ended September 30, 2016 and for the six months ended March 31, 2017 and the Company has a working capital deficit as of March 31, 2017. These conditions raise substantial doubt about the Company&amp;#8217;s ability to continue as a going concern.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;To continue as a going concern, the Company is dependent on achievement of cash flow and future profits from entering the production stage of operations. The Company does not have adequate liquidity to fund its current operations, meet its obligations and continue as a going concern. The Company currently has an &amp;#8220;equity line&amp;#8221; financing arrangement under a Purchase Agreement with L2 Capital, LLC.&amp;#160; In the past the Company has secured working capital loans to assist in financing its activities for the near term. The Company may also pursue other financing alternatives from time to time, including short-term operational strategic financing or equity financing, to fund its activities until it can achieve cash flow and profits from its operations. The Company&amp;#8217;s consolidated financial statements do not include any adjustment relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence. &lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Fair Value of Financial Instruments&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The fair values of the Company&amp;#8217;s financial instruments, which include cash, investments, accounts payable, accrued expenses and notes payable, approximate their carrying amounts because of the short maturities of these instruments or because of restrictions.&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:UseOfEstimates contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Management Estimates and Assumptions&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The preparation of the Company&amp;#8217;s unaudited consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made; however, actual results could differ materially from these estimates.&lt;/div&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Cash and Cash Equivalents&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company considers&#13;those short-term, highly liquid investments with maturities of three months or less as cash and cash equivalents. At times, cash&#13;in banks may be in excess of the FDIC limits. The Company has no cash equivalents.&lt;/div&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <ecpn:AdvancesToVendorPolicy contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Advances to Vendor&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company has made advances to the operator of a pilot plant which has been established to house equipment obtained from China that processes concentrates recovered at the El Capitan Property. The pilot plant, including the equipment, is owned by the operator of the pilot plant and not by the Company. The advances made by the Company are for site improvements, equipment and ancillary equipment required to attain the through put goal of management. The pilot plant is currently operational and generating concentrated product that is being shipped out to various refiners for processing and the Company is waiting for results from these refiners and any required specification requirements.&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The arrangements for repayment are included in the operating agreement with the operator. From proceeds of precious metal concentrates sales, all operating expenses incurred by each party for the period are reimbursed to the parties to the Agreement. The remaining profit for the period is divided equally and the plant operator from their profits must reimburse the Company for any advances made for equipment purchases and related modifications to equipment or the site.&lt;/div&gt;&lt;/div&gt;</ecpn:AdvancesToVendorPolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Inventory&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Inventories include mineralized material stockpile, concentrate, iron ore inventories and road base, as described below. Inventories are carried at the lower of average cost or net realizable value, in the case of mineralized material stockpile and concentrate inventories and minimal cost is attributable to the iron ore inventories. The net realizable value of mineralized material stockpile inventories represents the estimated future sales price of the product based on current and long-term metals prices, less the estimated costs to complete production and bring the product to sale. Concentrate inventories are carried at the lower of full cost of production or net realizable value based on current metals prices. Write-downs of inventory will be reported as a component of production costs applicable to sales.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;Mineralized Material&lt;/font&gt;&amp;#160;&lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;Stockpile Inventories&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Mineralized material stockpile inventories represent mineralized materials that have been mined and are available for further processing. Costs are allocated to mineralized material stockpile inventories based on relative values of material stockpiled and processed using current mining costs incurred up to the point of stockpiling the mineralized material.&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Concentrates&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Concentrates inventory include metal concentrates located either at the Company&amp;#8217;s El Capitan Property mine site or in transit to a customer&amp;#8217;s port. Inventories consist of mineralized material that contains gold and silver mineralization.&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Iron Ore&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Iron ore material is inventoried until the market prices are reestablished at a higher market demand and are valued at approximately $20 a ton. Any proceeds from the sale of iron ore will offset the cost of mining the mineralized ore.&lt;/div&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Property and Equipment&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Property and equipment are recorded at cost less accumulated depreciation. Upon retirement or sale, the cost of the assets disposed of and the related accumulated depreciation are removed from the accounts, with any resultant gain or loss being recognized as a component of operating income or expense. Depreciation is computed over the estimated useful lives of the assets using the straight-line method. Maintenance and repairs are charged to operations as incurred.&amp;#160;&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Restricted Cash&lt;/div&gt;&#13;&#13;&lt;div&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Restricted cash&#13;consists of two certificates of deposits in favor of the New Mexico Minerals and Mining Division for a total of $79,857. The amount&#13;is posted as a financial assurance for required reclamation work to be completed on mined and disturbed acreage.&lt;/div&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:CapitalizationOfInternalCostsPolicy contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Exploration Property Costs&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Exploration property costs are expensed as incurred until such time as economic reserves are quantified. To date the Company has not established any proven or probable reserves on the El Capitan Property. The Company has capitalized $1,864,608 of exploration property acquisition costs reflecting its investment in the El Capitan Property.&lt;/div&gt;&lt;/div&gt;</us-gaap:CapitalizationOfInternalCostsPolicy>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Derivative Financial Instruments&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company does not use derivative instruments to hedge exposures to cash flow or market risks. The Company reviews the terms of convertible debt, equity instruments and other financing arrangements to determine whether there are embedded derivative instruments, including embedded conversion options that are required to be bifurcated and accounted for separately as a derivative financial instrument. Also, in connection with the issuance of financing instruments, the Company may issue freestanding options or warrants that may, depending on their terms, be accounted for as derivative instrument liabilities, rather than as equity. The Company may also issue options or warrants to non-employees in connection with consulting or other services.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Derivative financial instruments&#13;are initially measured at their fair value. For derivative financial instruments that are accounted for as liabilities, the&#13;derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in&#13;the fair value reported as charges or credits to income.&amp;#160;To the extent that the initial fair values of the freestanding&#13;and/or bifurcated derivative instrument liabilities exceed the total proceeds received, an immediate charge to income is&#13;recognized as a one day derivative loss, in order to initially record the derivative instrument liabilities at their fair&#13;value.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The discount from the face value of the convertible debt or equity instruments resulting from allocating some or all of the proceeds to the derivative instruments, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to income, using the effective interest method.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;When required to arrive at the fair value of derivatives associated with the convertible note and warrants, a Monte Carlo model was utilized that values the Convertible Note and Warrant based on average discounted cash flow factoring in the various potential outcomes by a Chartered Financial Analyst (&amp;#8216;CFA&amp;#8221;). In determining the fair value of the derivatives the CFA assumed that the Company&amp;#8217;s business would be conducted as a going concern.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is reassessed at the end of each reporting period. If reclassification is required, the fair value of the derivative instrument, as of the determination date, is reclassified. Any previous charges or credits to income for changes in the fair value of the derivative instrument are not reversed. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.&lt;/div&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: justify"&gt;Stock-Based Compensation&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;FASB ASC 718 requires&#13;companies to measure all stock compensation awards using a fair value method and recognize the related compensation cost in its&#13;financial statements. Beginning with the Company&amp;#8217;s quarterly period that began on October 1, 2006, the Company adopted the&#13;provisions of FASB ASC 718 and expenses the fair value of employee stock options and similar awards in the financial statements.&#13;The Company accounts for share-based payments in accordance with ASC 718, &lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;i&gt;Compensation&#13;- Stock Compensation&lt;/i&gt;&lt;/font&gt;, which requires all share-based payments to employees, including grants of employee stock options,&#13;to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9,&#13;&amp;#8220;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;i&gt;Measurement Objective &amp;#8211; Fair Value at&#13;Grant Date&lt;/i&gt;&lt;/font&gt;,&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;i&gt;&amp;#8221;&lt;/i&gt;&lt;/font&gt; the Company&#13;estimates the fair value of the award using the Black-Scholes option pricing model for valuation of the share-based payments.&#13;The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change&#13;over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. The simplified&#13;method is used to determine compensation expense since historical option exercise experience is limited relative to the number&#13;of options issued. The compensation cost is recognized ratably using the straight-line method over the expected vesting period.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company accounts for stock-based compensation to other than employees in accordance with FASB ASC 505-50. Equity instruments issued to other than employees are valued at the earlier of a commitment date or upon completion of the services, based on the fair value of the equity instruments and is recognized as expense over the service period.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The Company recognized stock-based administrative compensation aggregating $-0- and $132,358 for common stock options and common stock issued to administrative personnel, directors and consultants during the six months ended March 31, 2017 and 2016, respectively.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;During the six month period ended March 31, 2017, the Company recognized stock compensation to our mine contractor of $206,813 and none for the comparable prior period of measurement. These costs incurred were attributable to the pilot plant operation and &lt;font style="font: 10pt Times New Roman, Times, serif; color: #000000"&gt;Mine Safety and Health Administration (&amp;#8220;MSHA&amp;#8221;)&lt;/font&gt; mine regulation consulting.&lt;/div&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Revenue Recognition&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;When revenue is generated from operations, it will be recognized in accordance with FASB ASC 605. In general, the Company will recognize revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered, (iii) the fee is fixed or determinable, and (iv) collectability is reasonably assured. Revenue generated and costs incurred under this agreement will be reported on a net basis in accordance with FASB ASC 605-45. There was no revenue generated for the Company&amp;#8217;s quarters ended March 31, 2017 and 2016, respectively.&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;Recently Issued Accounting Pronouncements&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Other than as set forth below, management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;In January 2016, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;)&amp;#160; 2016-01, &lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;&amp;#8220;Financial Instruments - Recognition and Measurement of Financial Assets and Financial Liabilities (Subtopic 825-10).&amp;#8221;&lt;/font&gt; The amendments require all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under the equity method of accounting or those that result in consolidation of the investee). The amendments also require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments. In addition, the amendments eliminate the requirement to disclose the fair value of financial instruments measured at amortized cost for entities that are not public business entities and the requirement to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet for public business entities. This guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not expect to early adopt this guidance and does not believe that the adoption of this guidance will have a material impact on its consolidated financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;In March 2016,&#13;the FASB issued ASU No. 2016-09, &amp;#8220;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;i&gt;Compensation&#13;- Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.&amp;#8221; &lt;/i&gt;&lt;/font&gt;ASU 2016-09 amends&#13;several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of&#13;awards as either equity or liabilities and classification on the statement of cash flows. ASU 2016-09 is effective for fiscal&#13;years beginning after December 15, 2016, including interim periods within those fiscal years. Early adoption is permitted any&#13;interim or annual period. If early adopted, an entity must adopt all of the amendments in the same period. The Company is currently&#13;evaluating the potential impact of the adoption of ASU 2016-09 on the Company's consolidated financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; color: #000000; text-align: left; text-indent: 36pt"&gt;In August, 2016, the FASB issued ASU No. 2016-15, &amp;#8220;&lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments&amp;#8221;&lt;/font&gt; (a consensus of the Emerging Issues Task Force). Effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2018, and interim periods within fiscal years beginning after December 15, 2019. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. An entity that elects early adoption must adopt all of the amendments in the same period.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; color: #000000; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC during the current reporting period did not, or are not believed by management to have a material impact on the Company&amp;#8217;s present or future consolidated financial statements.&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;The following table provides the components of inventory as of March 31, 2017 and September 30, 2016:&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="z1774afb50b0a4d6382f50f085ff7c75b" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 80%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;March 31,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;September 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Mineralized material stockpile&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;87,840&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;87,840&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Concentrate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;150,522&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;146,738&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Iron ore&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;17,888&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;17,888&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;256,250&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;252,466&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 36pt"&gt;Accrued liabilities consisted of the following as of March 31, 2017 and September 30, 2016:&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;table id="z9d0d3e0f05f44489a493f52eb9466785" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 80%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;March 31,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;September 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="3" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Mining costs&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;60,613&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Accounting and legal&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;83,309&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;285,025&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Interest&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;75,008&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;61,694&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 70%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;158,317&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;407,332&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;The components of the notes payable, including the note payable to related party, at March 31, 2017 are as follows:&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;table id="z4d1a82ed1c9d4d72b029574eeba613b9" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 80%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Principal&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Unamortized&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Amount&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Discount&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Net&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Notes payable&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;454,536&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;454,536&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Convertible note payable&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;110,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;(102,426&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;7,574&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Notes payable &amp;#8211; related party&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;30,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;30,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;594,536&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;(102,426&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;492,110&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;The components of the notes payable at September 30, 2016 are as follows:&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;table id="z1abaee433866418793c8f0057b098563" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 80%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Principal&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Unamortized&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Amount&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Discount&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Net&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Notes payable&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;858,988&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;(1,769&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;857,219&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Notes payable &amp;#8211; related party&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;30,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;30,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 55%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;888,988&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;(1,769&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;887,219&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="From2016-10-01to2017-03-31">&lt;table id="z9146a88b500b45ddbd50ba795b5bd6f4" cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;March 31, 2017:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Level 1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Level 2&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Level 3&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Assets&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Exploration property&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;1,864,608&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;1,864,608&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Liabilities&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Derivative instruments liability&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;311,652&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;311,652&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;table id="z15e5e22f6bad463aa656dbb057e32b12" cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;September 30, 2016:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Level 1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Level 2&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Level 3&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Assets&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Exploration property&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;1,864,608&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;1,864,608&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Liabilities&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;None&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Stock option activity, both within and outside the 2015 Plan, and warrant activity for the six months ended March 31, 2017, are as follows:&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="z621164e3a2ae428bae97444a78f1e8c8" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 80%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Stock Options&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Stock Warrants&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Weighted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Average&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Exercise&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Shares&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Outstanding at September 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;11,137,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;0.265&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;5,332,773&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;0.071&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;3,559,749&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;.129&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Canceled&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;(602,406&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;.365&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Expired&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Exercised&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Outstanding at March 31, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;11,137,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;0.265&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;8,290,116&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;0.075&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 40%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Exercisable at March 31, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;11,137,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;0.265&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;8,290,116&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;0.075&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">366254777</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">403745200</us-gaap:CommonStockSharesIssued>
    <ecpn:StockBasedCompensationPaidToMineContractor contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">206813</ecpn:StockBasedCompensationPaidToMineContractor>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2017-03-31_custom_NoteAndWarrantPurchaseAgreementMember" unitRef="UsdPerShare" decimals="INF">0.08126</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="UsdPerShare" decimals="INF">0.0913</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <ecpn:VestingWarrantPeriod contextRef="From2016-10-01to2017-03-31_custom_ConvesionAgreementMember">P3Y</ecpn:VestingWarrantPeriod>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet contextRef="AsOf2017-02-21_us-gaap_NoteWarrantMember_custom_InvestorAgreementMember" unitRef="USD" decimals="0">256028</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet contextRef="AsOf2017-02-21_us-gaap_NotesPayableOtherPayablesMember_custom_InvestorAgreementMember" unitRef="USD" decimals="0">71635</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet contextRef="AsOf2017-03-31_us-gaap_NoteWarrantMember_custom_InvestorAgreementMember" unitRef="USD" decimals="0">265093</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet contextRef="AsOf2017-03-31_custom_InvestorAgreementMember_us-gaap_NotesPayableOtherPayablesMember" unitRef="USD" decimals="0">46559</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet>
    <us-gaap:DerivativeLossOnDerivative contextRef="From2017-02-01to2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="USD" decimals="0">239334</us-gaap:DerivativeLossOnDerivative>
    <ecpn:AdvanceOutstandingAmount contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="USD" decimals="0">100000</ecpn:AdvanceOutstandingAmount>
    <ecpn:AttributableOutstandingAmount contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="USD" decimals="0">110000</ecpn:AttributableOutstandingAmount>
    <ecpn:PercentageOfEachAdvanceAmount contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="Pure" decimals="INF">1.10</ecpn:PercentageOfEachAdvanceAmount>
    <ecpn:InitialAdvanceAmount contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="USD" decimals="0">100000</ecpn:InitialAdvanceAmount>
    <ecpn:OutstandingAmountUnderNoteWillImmediatelyIncrease contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="Pure" decimals="INF">1.40</ecpn:OutstandingAmountUnderNoteWillImmediatelyIncrease>
    <ecpn:ConversionPriceWillBePermanentlyRedefinedToEqual contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="Pure" decimals="INF">0.60</ecpn:ConversionPriceWillBePermanentlyRedefinedToEqual>
    <ecpn:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="UsdPerShare" decimals="INF">0.08126</ecpn:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
    <ecpn:ClassOfWarrantOrRightOutstandingIncreased contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="Shares" decimals="INF">2707343</ecpn:ClassOfWarrantOrRightOutstandingIncreased>
    <ecpn:ConvertibleNoteAndWarrantBasedOnAverageDiscountedCashFlow contextRef="AsOf2017-03-31" unitRef="Pure" decimals="INF">500000</ecpn:ConvertibleNoteAndWarrantBasedOnAverageDiscountedCashFlow>
    <ecpn:ConvertibleNoteAndWarrantBasedOnAverageDiscountedCashFlow contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="Pure" decimals="INF">500000</ecpn:ConvertibleNoteAndWarrantBasedOnAverageDiscountedCashFlow>
    <ecpn:StockIssuedDuringPeriodValueIssuedForPrepaymentOfServicesOperatingCost contextRef="From2016-10-01to2017-03-31_custom_ContractMinersMember" unitRef="USD" decimals="0">188813</ecpn:StockIssuedDuringPeriodValueIssuedForPrepaymentOfServicesOperatingCost>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2016-10-01to2017-03-31_custom_TwoThousandsSixteenPurchaseAgreementMember" unitRef="Shares" decimals="INF">7684671</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2016-10-01to2017-03-31_custom_TwoThousandsSeventeenPurchaseAgreementMember" unitRef="Shares" decimals="INF">685396</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2016-10-01to2017-03-31_custom_TwoThousandsSixteenPurchaseAgreementMember" unitRef="USD" decimals="0">344576</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2016-10-01to2017-03-31_custom_TwoThousandsSeventeenPurchaseAgreementMember" unitRef="USD" decimals="0">39582</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2017-02-20to2017-02-21_custom_L2CapitalMember_us-gaap_MinimumMember" unitRef="USD" decimals="0">5000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2017-02-20to2017-02-21_custom_L2CapitalMember_us-gaap_MaximumMember" unitRef="USD" decimals="0">150000</us-gaap:StockIssuedDuringPeriodValueOther>
    <ecpn:IssuedSharesOfS8CommonStockToMineConsultant contextRef="From2016-10-01to2017-03-31" unitRef="Shares" decimals="INF">200000</ecpn:IssuedSharesOfS8CommonStockToMineConsultant>
    <ecpn:IssuedSharesOfS8CommonStockToMineConsultantMarketValue contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">18000</ecpn:IssuedSharesOfS8CommonStockToMineConsultantMarketValue>
    <us-gaap:CostOfRevenue contextRef="From2016-10-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfRevenue contextRef="From2017-01-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfRevenue contextRef="From2016-01-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfRevenue contextRef="From2015-10-01to2016-03-31" unitRef="USD" decimals="0">3300</us-gaap:CostOfRevenue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures contextRef="From2016-10-01to2017-03-31" unitRef="Shares" decimals="INF">602406</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2015-02-01to2015-02-04_us-gaap_UnsecuredDebtMember_custom_MriMember" unitRef="USD" decimals="0">30000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2016-10-01to2017-03-31" unitRef="USD" decimals="0">150000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2015-10-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2016-10-01to2017-03-31_custom_NoteAndWarrantPurchaseAgreementMember" unitRef="USD" decimals="0">150000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2016-01-01to2016-03-31_custom_NoteAndWarrantPurchaseAgreementMember" unitRef="USD" decimals="0">100000</us-gaap:RepaymentsOfNotesPayable>
    <ecpn:CommonStockSharesAuthorizedContractMiner contextRef="AsOf2017-03-29" unitRef="Shares" decimals="INF">3000000</ecpn:CommonStockSharesAuthorizedContractMiner>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2017-03-31_custom_ConvesionAgreementMember" unitRef="Shares" decimals="INF">250000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2017-03-31_custom_ConversionAgreementMember" unitRef="Shares" decimals="INF">250000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2016-01-04to2016-01-05_custom_LogisticaNoteMember" unitRef="USD" decimals="0">-100000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="AsOf2011-01-19" unitRef="Pure" decimals="INF">1.00</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <ecpn:PropertySiteOwnershipPercentage contextRef="AsOf2017-03-31" unitRef="Pure" decimals="INF">1.00</ecpn:PropertySiteOwnershipPercentage>
    <ecpn:AggregateMonthlyPaymentsUnderTheInformalArrangements contextRef="AsOf2009-05-01_us-gaap_OfficerMember" unitRef="USD" decimals="0">6667</ecpn:AggregateMonthlyPaymentsUnderTheInformalArrangements>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="From2016-10-01to2017-03-31">&lt;div&gt;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;NOTE 6 &amp;#8211; FAIR VALUE MEASUREMENTS&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;U.S. accounting standards require disclosure of a fair-value hierarchy of inputs the Company uses to value an asset or a liability. In September 2006, the FASB issued new accounting guidance, which establishes a framework for measuring fair value under generally accepted accounting principles (&amp;#8220;GAAP&amp;#8221;) and expands disclosures about fair value measurements. The Company previously partially adopted this guidance for all instruments recorded at fair value on a recurring basis. In the second quarter of fiscal 2010, the Company adopted the remaining provisions of the guidance for all non-financial assets and liabilities that are not re-measured at fair value on a recurring basis. The adoption of these provisions did not have an impact on the Company&amp;#8217;s consolidated financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Fair value standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, the standards establish a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires that the Company maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of the fair-value hierarchy are described as follows:&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Level 1 &amp;#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Level 2 &amp;#8211; Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Level 3 &amp;#8211; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&amp;#8217;s best estimate of fair value.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;The following table sets forth by level with the fair value hierarchy the Company&amp;#8217;s financial assets and liabilities measured at fair value on March 31, 2017 and September 30, 2016&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; clear: both"&gt;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;table id="z9146a88b500b45ddbd50ba795b5bd6f4" cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;March 31, 2017:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Level 1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Level 2&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Level 3&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Assets&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Exploration property&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;1,864,608&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;1,864,608&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Liabilities&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Derivative instruments liability&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;311,652&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;311,652&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;table id="z15e5e22f6bad463aa656dbb057e32b12" cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: left"&gt;September 30, 2016:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Level 1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Level 2&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Level 3&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif; text-align: center"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Assets&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td colspan="3" style="vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;Exploration property&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;1,864,608&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;1,864,608&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;Liabilities&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; margin-left: 9pt"&gt;None&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 0.95%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: right"&gt;&amp;#8212;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: justify; clear: both; text-indent: 36pt"&gt;The exploration property associated with the El Capitan Property, which the Company is intending to continue to market for sale to a major mining company, is classified as Level 3. The fair value of the exploration property is determined based upon the cost basis the of the Company&amp;#8217;s investment in the exploration property under U.S. GAAP. There was no change in the carrying valuation of the exploration property during the six months ended March 31, 2017.&lt;/div&gt;&#13;&#13;&lt;div&gt;&lt;br /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif; text-align: left; text-indent: 36pt"&gt;Complex derivative instrument liabilities utilize a Monte Carlo model to estimate their fair value. As set forth in the Statement of Financial Accounting Standard No. 820-10-35-37 &lt;font style="font: italic 10pt Times New Roman, Times, serif"&gt;Fair Value in Financial Instruments &lt;/font&gt;to increase consistency, a fair value hierarchy was developed to rank the reliability of inputs that reflect assumptions, used as a basis for determining fair value. The ASC 820 accounting standard requires companies use actual market data, when available or models, when unavailable. A quoted price in an active market provides the most reliable evidence of fair value and shall be used to measure fair value whenever available, except when it might not represent fair value at the measurement date. When using models, ASC 820 provides guidance on appropriate valuation techniques and addresses the inherent valuation issue of risk. A two-step approach is used in determining whether an instrument or embedded feature is indexed to an entity&amp;#8217;s own stock. First, the instrument's contingent exercise provisions, if any, must be evaluated, followed by an evaluation of the instrument's settlement provisions. Fair Value relied on a &amp;#8220;value in use&amp;#8221; or &amp;#8220;going concern&amp;#8221; premise. To properly apply this fair value standard, we gave consideration to the Holder&amp;#8217;s intentions regarding whether or not the Securities purchased were to be held, sold, or abandoned. Our analysis also reflects assumptions that would be made by market participants if these market participants were to buy or sell each identified asset on an individual basis&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;. The &lt;/font&gt;Monte Carlo model that values the Convertible Note and Warrant based on average discounted cash flow of 500,000 iterations factoring in the various potential outcomes. The derivative instrument liabilities on the convertible note and warrants at March 31, 2017 were $46,559 and $265,094, respectively.&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <ecpn:StockIssuedDuringPeriodSharesInducementOfExtension contextRef="From2015-02-01to2015-02-04_us-gaap_UnsecuredDebtMember_custom_MriMember_us-gaap_RestrictedStockMember" unitRef="Shares" decimals="INF">200000</ecpn:StockIssuedDuringPeriodSharesInducementOfExtension>
    <ecpn:StockIssuedDuringPeriodSharesInducementOfExtension contextRef="From2015-02-01to2015-02-04_us-gaap_UnsecuredDebtMember" unitRef="Shares" decimals="INF">400000</ecpn:StockIssuedDuringPeriodSharesInducementOfExtension>
    <ecpn:StockIssuedDuringPeriodSharesInducementOfExtension contextRef="From2015-02-01to2015-02-04_us-gaap_UnsecuredDebtMember_us-gaap_RestrictedStockMember" unitRef="Shares" decimals="INF">200000</ecpn:StockIssuedDuringPeriodSharesInducementOfExtension>
    <ecpn:StockIssuedDuringPeriodSharesInducementOfExtension contextRef="From2016-02-01to2016-02-04_us-gaap_UnsecuredDebtMember_us-gaap_RestrictedStockMember_custom_MriMember" unitRef="Shares" decimals="INF">150000</ecpn:StockIssuedDuringPeriodSharesInducementOfExtension>
    <ecpn:StockIssuedDuringPeriodSharesInducementOfExtension contextRef="From2016-02-01to2016-02-04_us-gaap_UnsecuredDebtMember_custom_OneOfTheLendersAffiliatedWithTheCompanyMember_us-gaap_RestrictedStockMember" unitRef="Shares" decimals="INF">200000</ecpn:StockIssuedDuringPeriodSharesInducementOfExtension>
    <us-gaap:LegalFees contextRef="From2016-10-01to2017-03-31_custom_AccruedLegalFeesMember" unitRef="USD" decimals="0">236755</us-gaap:LegalFees>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets contextRef="From2014-02-01to2014-02-28_custom_LogisticaNoteMember" unitRef="Shares" decimals="INF">2500000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2015-02-01to2015-02-04_us-gaap_UnsecuredDebtMember_custom_MriMember" unitRef="USD" decimals="0">21211</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <ecpn:StockIssuedDuringPeriodSharesPriorServicesRendered contextRef="From2016-08-01to2016-08-31_custom_LogisticaNoteMember" unitRef="Shares" decimals="INF">10000000</ecpn:StockIssuedDuringPeriodSharesPriorServicesRendered>
    <us-gaap:InterestPaid contextRef="From2016-10-01to2017-03-31_custom_NoteAndWarrantPurchaseAgreementMember" unitRef="USD" decimals="0">6115</us-gaap:InterestPaid>
    <ecpn:StockIssuedDuringPeriodSharesConversionOfPrincipalAndAccruedInterest contextRef="From2016-10-01to2017-03-31_custom_ConvesionAgreementMember" unitRef="Shares" decimals="INF">3150719</ecpn:StockIssuedDuringPeriodSharesConversionOfPrincipalAndAccruedInterest>
    <ecpn:ClassOfWarrantOrRightCancelled contextRef="AsOf2015-08-24_custom_NoteAndWarrantPurchaseAgreementMember" unitRef="Shares" decimals="INF">882352</ecpn:ClassOfWarrantOrRightCancelled>
    <ecpn:ClassOfWarrantOrRightTerm contextRef="From2017-02-01to2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember">P3Y</ecpn:ClassOfWarrantOrRightTerm>
    <ecpn:WarrantsToBeIssuedAsAPercentageOfConversionSharesIssuable contextRef="AsOf2017-02-21_us-gaap_InvestorMember_custom_InvestorAgreementMember" unitRef="Pure" decimals="INF">0.50</ecpn:WarrantsToBeIssuedAsAPercentageOfConversionSharesIssuable>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="From2017-01-01to2017-03-31_custom_InvestorAgreementMember" unitRef="USD" decimals="0">16011</us-gaap:DerivativeGainLossOnDerivativeNet>
    <ecpn:UnamortizedDiscountOnNotePayable contextRef="AsOf2017-03-31_custom_InvestorAgreementMember" unitRef="USD" decimals="0">102426</ecpn:UnamortizedDiscountOnNotePayable>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2017-03-31_custom_LogisticaNoteMember" unitRef="USD" decimals="0">55578</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2017-03-31_us-gaap_UnsecuredDebtMember_custom_MriMember" unitRef="USD" decimals="0">16120</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2017-03-31_custom_ConvesionAgreementMember" unitRef="USD" decimals="0">6027</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2016-02-04_us-gaap_UnsecuredDebtMember_custom_MriMember" unitRef="USD" decimals="0">5940</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2017-03-31_custom_InvestorAgreementMember" unitRef="USD" decimals="0">823</us-gaap:InterestPayableCurrent>
    <ecpn:MaximumGrossProceeds contextRef="From2017-02-20to2017-02-21_custom_L2CapitalMember" unitRef="USD" decimals="0">5000000</ecpn:MaximumGrossProceeds>
    <ecpn:SharesPursuantToPurchaseAgreementForAggregatePurchasePrice contextRef="AsOf2017-02-21" unitRef="Shares" decimals="INF">5000000</ecpn:SharesPursuantToPurchaseAgreementForAggregatePurchasePrice>
    <ecpn:PurchaseAgreementTerminationDate contextRef="From2017-02-20to2017-02-21_custom_L2CapitalMember">2020-02-21</ecpn:PurchaseAgreementTerminationDate>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction contextRef="From2017-02-20to2017-02-21_custom_L2CapitalMember_us-gaap_MaximumMember" unitRef="Pure" decimals="INF">0.0999</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <ecpn:PercentageOfMarketPrice contextRef="From2017-02-20to2017-02-21_custom_L2CapitalMember" unitRef="Pure" decimals="INF">0.85</ecpn:PercentageOfMarketPrice>
    <ecpn:DiscountToMarketPrice contextRef="From2017-02-20to2017-02-21_custom_L2CapitalMember" unitRef="Pure" decimals="INF">0.10</ecpn:DiscountToMarketPrice>
    <us-gaap:SharePrice contextRef="AsOf2017-02-21_custom_L2CapitalMember_us-gaap_MaximumMember" unitRef="UsdPerShare" decimals="INF">0.10</us-gaap:SharePrice>
    <ecpn:TradingVolume contextRef="From2017-02-20to2017-02-21_custom_L2CapitalMember_us-gaap_MaximumMember" unitRef="USD" decimals="0">50000</ecpn:TradingVolume>
    <ecpn:DiscountForDWACIneligibility contextRef="From2017-02-20to2017-02-21_custom_L2CapitalMember" unitRef="Pure" decimals="INF">0.05</ecpn:DiscountForDWACIneligibility>
    <ecpn:DiscountPercentageForDTCChill contextRef="From2017-02-20to2017-02-21_custom_L2CapitalMember" unitRef="Pure" decimals="INF">0.10</ecpn:DiscountPercentageForDTCChill>
    <ecpn:RegistrationStatementSharesAmount contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">25000000</ecpn:RegistrationStatementSharesAmount>
</xbrli:xbrl>
